Podcasts about tangentially

Links: https://www.ksl.com/article/51305830/family-of-missionary-killed-in-north-carolina-auto-pedestrian-crash-says-he-was-excited-to-serve?fbclid=IwY2xjawKHCAZleHRuA2FlbQIxMQBicmlkETFGRmE3cTJwa2xObjRTOGJoAR5U0g3Ezqut0_CKeaFsbQyUYYhQgpEKKCo3gnfoH-3lRVa8bpGCTgul6OCtKQ_aem_u_4K9c-algIdfzbKaoNeuw https://www.fox13now.com/news/local-news/northern-utah/historic-salt-lake-city-church-to-be-restored-as-recovery-housing-after-city-approval?fbclid=IwY2xjawKHCVRleHRuA2FlbQIxMQBicmlkETFGRmE3cTJwa2xObjRTOGJoAR7e-dLKqH-CAgqnr69Kdk-zOiZpXhJyxTCiApVUkWHdkt57k5w5Df-2_cLfSg_aem_ItJeVQRitD-iuU84xQAhWQ https://publicsquaremag.org/faith/gospel-fare/listen-to-women-church-today/ https://www.deseret.com/sports/2025/05/04/byu-basketball-players-participating-in-international-goodwill-trips/?utm_source=twitter&utm_medium=dn-social&utm_campaign=twitter&utm_content=deseretnews&fbclid=IwY2xjawKHCi1leHRuA2FlbQIxMQBicmlkETFGRmE3cTJwa2xObjRTOGJoAR4KklDm8v0aUZUtwkGuswFHnHCz6y_rp1rAQZRbRdVxtNW3hJYBawRN4mblRA_aem_b5U1s-la32APDEs1THjbHQ https://newsroom.churchofjesuschrist.org/article/rendering-released-colorado-springs-temple https://newsroom.churchofjesuschrist.org/article/first-district-of-the-church-created-in-guinea-west-africa#:~:text=The%20first%20district%20of%20The,reported%20the%20Church's%20Africa%20Newsroom. https://news-africa.churchofjesuschrist.org/article/abidjan-ivory-coast-temple-open-house-begins https://www.espn.com/nhl/story/_/id/45036623/utah-picks-mammoth-mascot-end-yearlong-search? Tangentially related because it's Utah. Also Mormonr quickly memed this with a Utah Curelom logo that seemed much more fitting. https://apnews.com/live/conclave-pope-catholic-church-updates-5-8-2025 first american pope. https://newsroom.churchofjesuschrist.org/article/first-presidency-message-new-pope 168: Thank You!! And Goodbye for Now... Michelle Stone is taking down her controversial podcast. Or is she? https://newsroom.churchofjesuschrist.org/article/bishop-causse-crossroads-world-international-trade-summit

The girls review a celebrity bake-off from 2019 this episode.  Lisa explains the difficulty in finding recognizable British celebrities, and both girls embark on a John Lithgow discussion.  Sidestepping Russell Brand's current problems, the girls reject his use of fondant for the first challenge, and Lisa queries Allison on her go-to home-baked brownie.  A swiss roll technical prompts Lisa to challenge herself to try a patterned version of her own this summer, then, she recommends a frozen Little Debbie snack cake version. Tangentially, the girls discuss their favorite childhood sweet treat, and appropriate a kid's Christmas song from 1960.The biscuit showstopper highlights the episode's winner and the Celebrity Bake-off  prize -- an apron. Lisa mentions her love of aprons, and, a particular favorite she received from a particularly close friend...Connect with us:https://soggybottomgirls.com Follow us on social media:Facebook: https://www.facebook.com/soggybottomgirlsInstagram: https://www.instagram.com/soggybottomgirls/

According to research from Gartner, only 24% of workers have a high degree of readiness to adopt new technology. So how can you optimize your enablement tech stack to build excitement and drive adoption from the start? Shawnna Sumaoang: Hi, and welcome to the Win-Win podcast. I’m your host, Shawnna Sumaoang. Join us as we dive into changing trends in the workplace and how to navigate them successfully. Here to discuss this topic is Karen Gauthier, senior Manager of growth enablement at Bright Horizons. Thank you for joining us. Karen. I’d love for you to tell us about yourself, your background, and your role. Karen Gauthier: Thank you for having me very much, Shawnna. I’ve been with Bright Horizons for about five years in sales enablement. Our role here is basically to support our sales and client relations teams and serve up the right content, messaging and procedures so that they can do their job as effectively and scalable wise as possible. Prior to that, I worked in a number of different organizations, most recently education related. And I started out doing technical and user documentation, writing, and then supporting the training of those documents with the user group. And it just kind of, you know, one thing led to another and I probably was doing enablement before they called it enablement, but here I am. So enjoy it very much. SS: Well, we’re glad you’re here, Karen. Thank you for joining us. And given your extensive experience in education management, what are some of the. Unique challenges that reps in the industry face. And how would you say enablement can help them navigate these challenges? KG: Yeah, well, specifically for Bright Horizons, we have a number of products and services that really run a span from onsite care through career development and college coach elder care, everything for the lifecycle of the workers of the employers that we support. And so needing to understand all of the needs and the different types of tools that help. Those employers retain and recruit employees and just make it a quality place to work. And a best in class place to work is a big ask. So our reps not only need to understand the broad strokes, but the details and our job. And I think that the job of enablement is to serve it up in bite-sized pieces, but not just content, but the context. So when given a specific. Situation, different client, different industry, all of the different regulations or legal or political things that are involved in, you know, care or working for a nonprofit, those types of things. I mean, a lot of that makes our content very dependent on a specific use, and so having a tool that is robust, scalable, and flexible for our users with a good interface is a game changer. SS: I love that. And your organization has evolved quite a bit. On the enablement front. You recently switched off a previous enablement platform and moved to Highspot. Can you tell us a little bit more about some of the challenges your team faced before and how you’ve been able to overcome those since implementing Highspot? KG: Sure. When I started with Bright Horizons, we were very new in the launch of that original tool, so we really did have it almost five years. I was there for kind of all of the growing pains, and I think that tool allowed us to understand what was available, what we could do. But I feel like at some point. It hit its limits of growth and scalability and you know, then there are always the little support issues, upgrades and things like that, that we just felt like we were needing a little bit more. So we went ahead and really took a good long look at our requirements matrix and what we needed and did our due diligence and came upon Highspot as the best in class for our needs. SS: I love that, and I think you made the right choice since you were a key advocate in the evaluation process. How did you build the business case for switching to a new enablement platform, and how did you go about securing stakeholder buy-in? KG: Yeah, I think that the first thing that we’ve tried to do that I think we learned using the original tool that we had was we had kind of sporadically throughout our user base, some key users that were early adopters and leaders on their teams, and we just kept them very closely in the loop as kind of team members. Tangentially so that they, they would be aware of what was going on. They could provide us feedback, what was working, what wasn’t, and using them as a sounding board, we were able to identify very quickly, not only what requirements we needed to kind of improve on with a new tool, but also prioritize them. And so being able to use that as our main business case. As our internal customers. Then when we went to the management, you know, ladder as we need to make a change and within our scope of budget, these are the priorities over the next three, six months and then a year and further, we were able to kind of take that scope of what we needed and the budget and the sale, and then having an internal coach and champion. Helped us navigate some of the internal procurement and technology things that needed to be tied together. So just kind of bringing everyone into the organization of understanding what needed to happen and prioritizing it was the most important thing for us. SS: Well, you must have done a phenomenal job on that front. The team did. Yeah. Team effort. Now, at your previous company, you participated in the implementation of Highspot. In your opinion, what are the key building blocks for a successful rollout of a new platform? KG: I mean, I think one of the biggest mistakes, and this goes back to my training and documentation days, is not stepping into the user’s day in the life. And, you know, there could be a hundred features in, in a particular tool, but they may use five of them 90% of the time. And so it, it’s a matter of really stepping into their shoes and understanding what needs to get done, what needs to get done at scale, what are some nuances. For the different ways their days could go and then incorporate that into the rollout prioritization plan. And, and that was something that part of the team I was on at a previous company did a really good job. And then, you know, kind of accepted all support from people that were willing to help in, in identifying little details of things that could go wrong down the road, not just the big picture, but. The little details, like there’s embedded links that are gonna go wrong in a script when that old tool goes away. And just identifying a lot of that stuff up front so you don’t have chaos day one. SS: Yeah. Well, I have to say your approach to stepping into their shoes must be working because you’ve already seen an impressive 85% recurring usage of Highspot. So I’d love to understand what are some of your best practices for driving adoption and really building excitement for your programs amongst the teams that you support? KG: Well, thank you for that. Our teams worked really hard, like I said, to have champions throughout the user base. We have users in the US separately in the UK, and then we have three different main lines of business. So it’s kind of spread out and all of them have unique needs, and so making sure that we bring them in so that not only do they feel part of the solution, but they can then go back and be champions and socialize it with their teams and, and we started that early on for this implementation. For a number of reasons. We had a very, very tight rollout. It was like five weeks, and so that was like all hands on deck. And the goal on the backend was just to kind of drill in, get as much done as we could, but outwardly we just kind of dripped out information, made it as positive as possible. And then I think the key to the adoption being successful was on day one, there were very few things that they used to do that they couldn’t still do. So that was priority one, was to kind of keep it. Status quo. And then once all the little bugs were worked out, then we started, you know, bringing out some of the features that we knew were very, very high on the priority list. And, the other thing we did was have a lot of opportunities for them to jump in as questions offered one-on-ones, jumped in on team calls, provided our own little videos and job aids for people, that kind of thing. Just so that there were a lot of communication tools out there so that they felt like they were always kind of having it in the forefront and, oh, I can do this, I can do that, and that seemed to just feed on itself and work well. SS: Amazing. Well, like I said, phenomenal job already. That is amazing. Now, as we head it into this year, I know one area that you plan on focusing on is enhancing buyer engagement. Can you share how you envision leveraging features like digital rooms to personalize and elevate the buyer journey? KG: That was one of the main tools, I think when we were out in the market looking for something to elevate our users into. That context was not just, you know, serving up the right brief at the right time because it’s the healthcare industry, but as part of a buyer journey. What pieces during an introductory BDR conversation would be more useful than like right before a finalist meeting. And so that was something that because we have a lot of deals going on concurrently, we wanted to be able to have something that we had a template for that could be reused, but also customizable with a pretty. Easy interface so that our users could make those changes. And it didn’t have to be gate kept by the admin group. So that was phase one was just kind of understanding that people were used to just dropping something in an email and sending it out, and we were losing not only the ability to repeat it, but we can track. Any of the information that was now available to us in engagements and we couldn’t relate it to opportunities, accounts, contacts in Salesforce and gain information that way. So we started out just really getting people used to the email pitches and link pitches so that they were getting a little more familiar with internally. In the tool, sending things out to prospects and clients, and that went really well. So then our new launch, which is something we’re working on now, we are, we have a few prototypes of some different digital sales rooms, and the initial feedback has been very positive. We’re hearing that they’re able to connect with people that had gone silent or share things and the response from their prospects has been that they like having one portal, that they know that information’s gonna get updated or the next time they go, if there’s an updated version, it’s gonna be there. And it’s been so far, very, very successful. We’re excited to expand it further, but I feel like just being three, four months into our launch of Highspot and being this far, being able to actually get this out there has been a big win. We’re excited about that. SS: Amazing. You touched on this a little bit, but I know you’re currently working on integrating Salesforce with Highspot. What value do you see in this integration and what outcomes are you hoping to achieve? KG: Well, I think because we don’t have one path to a sale or one path to a existing client, so I think right now we’re just kind of getting a feel for. What that data’s gonna look like when it comes in. I mean, we know theoretically what it’s gonna do, but right now we’re making sure that whenever somebody shares something externally or uses a digital sales room that they’re relating so that we can start gathering all of the engagement information, tie it back to Salesforce, and we’re hoping to see is which content is most useful, at which stages of the lifecycle of a deal, which pieces of content help push it? Further and are there gaps where there just wasn’t content at the right stage for the right type of deal so that we can be serving up the right content at the right time. So I think initially that’s, that’s what we hope to get is providing the right content and then later making sure that we can tighten up our sales playbook with what to use at the right time throughout the lifecycle. Some of our deals are very short, but you know, building a new center is months and months, so they’re very different. SS: It’s amazing though that you guys are using that integration and that data that you’re seeing to really understand the full buyer’s lifecycle, so that’s phenomenal. Since launching Highspot, I’d love to understand what results you’ve seen so far and are there any key wins or notable business outcomes you can share with us yet? KG: I don’t have anything very quantitative. I can just say that whatever we are receiving in terms of information about what people are viewing and which tools are which, which pieces of content are more receptive than others, that’s all a hundred percent in improvement over where we were before. Because some information’s better than no information. I think. The people that use it appreciate the ability to go in and make it theirs, but not have to start from scratch. I think they like the idea of being able to see the metrics of people’s use or lack of use, and then understanding there’s another way to go about reaching out to that person. People you know that have different comfort levels with technology. So, you know, some people are gonna be all in on just building this out internally in the tool. Some people are gonna wanna just grab a link and put it in an Outlook email, and their clients might be appreciative of one way and not another. So I think that was one of the big wins we found so far, is that the tool is flexible enough to give and take for what we need. SS: Amazing. Well, Karen, we’re excited that you’re on this journey with us. And now I will say, last question for you, if you don’t mind. For enablement leaders looking to effectively implement and drive adoption for their new enablement platform, what is maybe the biggest takeaway you’d leave them with? KG: I think you need to know your customer, which is the internal users, and I think that you just have to find the tool that matches as best you can, given your budget and then prioritize. You can’t boil the ocean, but you know, you can pick and choose and and get those wins and, and when you do get a good win at an early win, good news travels fast, and when the right people hear the right message, it just does build on the energy, which is. Very helpful for the new tools that we wanna bring out to them. Things like the AI, we’ve just started dipping our toe into what that can do for us, and being able to get those wins with your user base behind you allows you to have the flexibility to play with some of the new features and bring them more. SS: Amazing. Well, Karen, thank you so much for joining us. I really appreciate it. KG: My pleasure. Thanks for having me. SS: To our audience, thank you for listening to this episode of the Win-Win podcast. Be sure to tune in next time for more insights on how you can maximize enablement success with Highspot.

According to research from Gartner, only 24% of workers have a high degree of readiness to adopt new technology. So how can you optimize your enablement tech stack to build excitement and drive adoption from the start? Shawnna Sumaoang: Hi, and welcome to the Win-Win podcast. I’m your host, Shawnna Sumaoang. Join us as we dive into changing trends in the workplace and how to navigate them successfully. Here to discuss this topic is Karen Gauthier, senior Manager of growth enablement at Bright Horizons. Thank you for joining us. Karen. I’d love for you to tell us about yourself, your background, and your role. Karen Gauthier: Thank you for having me very much, Shawnna. I’ve been with Bright Horizons for about five years in sales enablement. Our role here is basically to support our sales and client relations teams and serve up the right content, messaging and procedures so that they can do their job as effectively and scalable wise as possible. Prior to that, I worked in a number of different organizations, most recently education related. And I started out doing technical and user documentation, writing, and then supporting the training of those documents with the user group. And it just kind of, you know, one thing led to another and I probably was doing enablement before they called it enablement, but here I am. So enjoy it very much. SS: Well, we’re glad you’re here, Karen. Thank you for joining us. And given your extensive experience in education management, what are some of the. Unique challenges that reps in the industry face. And how would you say enablement can help them navigate these challenges? KG: Yeah, well, specifically for Bright Horizons, we have a number of products and services that really run a span from onsite care through career development and college coach elder care, everything for the lifecycle of the workers of the employers that we support. And so needing to understand all of the needs and the different types of tools that help. Those employers retain and recruit employees and just make it a quality place to work. And a best in class place to work is a big ask. So our reps not only need to understand the broad strokes, but the details and our job. And I think that the job of enablement is to serve it up in bite-sized pieces, but not just content, but the context. So when given a specific. Situation, different client, different industry, all of the different regulations or legal or political things that are involved in, you know, care or working for a nonprofit, those types of things. I mean, a lot of that makes our content very dependent on a specific use, and so having a tool that is robust, scalable, and flexible for our users with a good interface is a game changer. SS: I love that. And your organization has evolved quite a bit. On the enablement front. You recently switched off a previous enablement platform and moved to Highspot. Can you tell us a little bit more about some of the challenges your team faced before and how you’ve been able to overcome those since implementing Highspot? KG: Sure. When I started with Bright Horizons, we were very new in the launch of that original tool, so we really did have it almost five years. I was there for kind of all of the growing pains, and I think that tool allowed us to understand what was available, what we could do. But I feel like at some point. It hit its limits of growth and scalability and you know, then there are always the little support issues, upgrades and things like that, that we just felt like we were needing a little bit more. So we went ahead and really took a good long look at our requirements matrix and what we needed and did our due diligence and came upon Highspot as the best in class for our needs. SS: I love that, and I think you made the right choice since you were a key advocate in the evaluation process. How did you build the business case for switching to a new enablement platform, and how did you go about securing stakeholder buy-in? KG: Yeah, I think that the first thing that we’ve tried to do that I think we learned using the original tool that we had was we had kind of sporadically throughout our user base, some key users that were early adopters and leaders on their teams, and we just kept them very closely in the loop as kind of team members. Tangentially so that they, they would be aware of what was going on. They could provide us feedback, what was working, what wasn’t, and using them as a sounding board, we were able to identify very quickly, not only what requirements we needed to kind of improve on with a new tool, but also prioritize them. And so being able to use that as our main business case. As our internal customers. Then when we went to the management, you know, ladder as we need to make a change and within our scope of budget, these are the priorities over the next three, six months and then a year and further, we were able to kind of take that scope of what we needed and the budget and the sale, and then having an internal coach and champion. Helped us navigate some of the internal procurement and technology things that needed to be tied together. So just kind of bringing everyone into the organization of understanding what needed to happen and prioritizing it was the most important thing for us. SS: Well, you must have done a phenomenal job on that front. The team did. Yeah. Team effort. Now, at your previous company, you participated in the implementation of Highspot. In your opinion, what are the key building blocks for a successful rollout of a new platform? KG: I mean, I think one of the biggest mistakes, and this goes back to my training and documentation days, is not stepping into the user’s day in the life. And, you know, there could be a hundred features in, in a particular tool, but they may use five of them 90% of the time. And so it, it’s a matter of really stepping into their shoes and understanding what needs to get done, what needs to get done at scale, what are some nuances. For the different ways their days could go and then incorporate that into the rollout prioritization plan. And, and that was something that part of the team I was on at a previous company did a really good job. And then, you know, kind of accepted all support from people that were willing to help in, in identifying little details of things that could go wrong down the road, not just the big picture, but. The little details, like there’s embedded links that are gonna go wrong in a script when that old tool goes away. And just identifying a lot of that stuff up front so you don’t have chaos day one. SS: Yeah. Well, I have to say your approach to stepping into their shoes must be working because you’ve already seen an impressive 85% recurring usage of Highspot. So I’d love to understand what are some of your best practices for driving adoption and really building excitement for your programs amongst the teams that you support? KG: Well, thank you for that. Our teams worked really hard, like I said, to have champions throughout the user base. We have users in the US separately in the UK, and then we have three different main lines of business. So it’s kind of spread out and all of them have unique needs, and so making sure that we bring them in so that not only do they feel part of the solution, but they can then go back and be champions and socialize it with their teams and, and we started that early on for this implementation. For a number of reasons. We had a very, very tight rollout. It was like five weeks, and so that was like all hands on deck. And the goal on the backend was just to kind of drill in, get as much done as we could, but outwardly we just kind of dripped out information, made it as positive as possible. And then I think the key to the adoption being successful was on day one, there were very few things that they used to do that they couldn’t still do. So that was priority one, was to kind of keep it. Status quo. And then once all the little bugs were worked out, then we started, you know, bringing out some of the features that we knew were very, very high on the priority list. And, the other thing we did was have a lot of opportunities for them to jump in as questions offered one-on-ones, jumped in on team calls, provided our own little videos and job aids for people, that kind of thing. Just so that there were a lot of communication tools out there so that they felt like they were always kind of having it in the forefront and, oh, I can do this, I can do that, and that seemed to just feed on itself and work well. SS: Amazing. Well, like I said, phenomenal job already. That is amazing. Now, as we head it into this year, I know one area that you plan on focusing on is enhancing buyer engagement. Can you share how you envision leveraging features like digital rooms to personalize and elevate the buyer journey? KG: That was one of the main tools, I think when we were out in the market looking for something to elevate our users into. That context was not just, you know, serving up the right brief at the right time because it’s the healthcare industry, but as part of a buyer journey. What pieces during an introductory BDR conversation would be more useful than like right before a finalist meeting. And so that was something that because we have a lot of deals going on concurrently, we wanted to be able to have something that we had a template for that could be reused, but also customizable with a pretty. Easy interface so that our users could make those changes. And it didn’t have to be gate kept by the admin group. So that was phase one was just kind of understanding that people were used to just dropping something in an email and sending it out, and we were losing not only the ability to repeat it, but we can track. Any of the information that was now available to us in engagements and we couldn’t relate it to opportunities, accounts, contacts in Salesforce and gain information that way. So we started out just really getting people used to the email pitches and link pitches so that they were getting a little more familiar with internally. In the tool, sending things out to prospects and clients, and that went really well. So then our new launch, which is something we’re working on now, we are, we have a few prototypes of some different digital sales rooms, and the initial feedback has been very positive. We’re hearing that they’re able to connect with people that had gone silent or share things and the response from their prospects has been that they like having one portal, that they know that information’s gonna get updated or the next time they go, if there’s an updated version, it’s gonna be there. And it’s been so far, very, very successful. We’re excited to expand it further, but I feel like just being three, four months into our launch of Highspot and being this far, being able to actually get this out there has been a big win. We’re excited about that. SS: Amazing. You touched on this a little bit, but I know you’re currently working on integrating Salesforce with Highspot. What value do you see in this integration and what outcomes are you hoping to achieve? KG: Well, I think because we don’t have one path to a sale or one path to a existing client, so I think right now we’re just kind of getting a feel for. What that data’s gonna look like when it comes in. I mean, we know theoretically what it’s gonna do, but right now we’re making sure that whenever somebody shares something externally or uses a digital sales room that they’re relating so that we can start gathering all of the engagement information, tie it back to Salesforce, and we’re hoping to see is which content is most useful, at which stages of the lifecycle of a deal, which pieces of content help push it? Further and are there gaps where there just wasn’t content at the right stage for the right type of deal so that we can be serving up the right content at the right time. So I think initially that’s, that’s what we hope to get is providing the right content and then later making sure that we can tighten up our sales playbook with what to use at the right time throughout the lifecycle. Some of our deals are very short, but you know, building a new center is months and months, so they’re very different. SS: It’s amazing though that you guys are using that integration and that data that you’re seeing to really understand the full buyer’s lifecycle, so that’s phenomenal. Since launching Highspot, I’d love to understand what results you’ve seen so far and are there any key wins or notable business outcomes you can share with us yet? KG: I don’t have anything very quantitative. I can just say that whatever we are receiving in terms of information about what people are viewing and which tools are which, which pieces of content are more receptive than others, that’s all a hundred percent in improvement over where we were before. Because some information’s better than no information. I think. The people that use it appreciate the ability to go in and make it theirs, but not have to start from scratch. I think they like the idea of being able to see the metrics of people’s use or lack of use, and then understanding there’s another way to go about reaching out to that person. People you know that have different comfort levels with technology. So, you know, some people are gonna be all in on just building this out internally in the tool. Some people are gonna wanna just grab a link and put it in an Outlook email, and their clients might be appreciative of one way and not another. So I think that was one of the big wins we found so far, is that the tool is flexible enough to give and take for what we need. SS: Amazing. Well, Karen, we’re excited that you’re on this journey with us. And now I will say, last question for you, if you don’t mind. For enablement leaders looking to effectively implement and drive adoption for their new enablement platform, what is maybe the biggest takeaway you’d leave them with? KG: I think you need to know your customer, which is the internal users, and I think that you just have to find the tool that matches as best you can, given your budget and then prioritize. You can’t boil the ocean, but you know, you can pick and choose and and get those wins and, and when you do get a good win at an early win, good news travels fast, and when the right people hear the right message, it just does build on the energy, which is. Very helpful for the new tools that we wanna bring out to them. Things like the AI, we’ve just started dipping our toe into what that can do for us, and being able to get those wins with your user base behind you allows you to have the flexibility to play with some of the new features and bring them more. SS: Amazing. Well, Karen, thank you so much for joining us. I really appreciate it. KG: My pleasure. Thanks for having me. SS: To our audience, thank you for listening to this episode of the Win-Win podcast. Be sure to tune in next time for more insights on how you can maximize enablement success with Highspot.

The european storm weekend is pulled apart, among other things Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Kraken are fresh off a solid three-game road trip, in which they picked up four out of six points, and got a big win in Nashville. The guys break down all three games and give their general thoughts about how things have been going so well for Seattle. Lots of in-depth Kraken talk in this one. They then go Down on the Farm, share a "You Don't See That Every Day," and close the show with Weekly One-Timers. SUBSCRIBE! ENJOY! REVIEW!

Remember you can join us live on YouTube every Thursday from 8pm (UK time)! Help support LDO on Patreon: https://www.patreon.com/letsdroneout Join our Discord: https://discord.com/invite/8hEVqkM Get our merch here: https://letsdroneout.com/shop Get our merch via Paypal: https://paypal.me/letsdroneout/GBP Email us at letsdroneout@gmail.com Follow us on Facebook: https://fb.com/letsdroneout Let's drone out is: Jack - https://www.youtube.com/user/brighton... Stephen - https://www.youtube.com/user/ShinyVid... CurryKitten - https://www.youtube.com/currykitten Koel -https://www.youtube.com/channel/UCqkF... Please consider becoming a Patreon and help the show keep running. Thank You! https://www.patreon.com/letsdroneout LEGAL NOTICE: Any views expressed by any guests on this show are personal and may not reflect the views of the hosts or any participant of the show.

Happy Wednesday, listening fam!  To start with this morning, John discusses the news of a plea agreement between the U.S. Government and international whistleblower Julian Assange.  Tangentially, John addresses the maliciousness of sucker-punch accusations about alleged sexual conduct long after the supposed fact, when corroborating -- or even discrediting -- them is nearly impossible.

The Big Suey kicks off with the crew honoring the life and legacy of Louis Gossett Jr., who passed away Friday, Tony reveals he has seen some of his movies tangentially, and Mike wants to discuss hockey and figure out where Amin's hockey allegiances lie. Plus, Nelson Cruz retiring with the Mariners sparks a conversation about one-day contracts, and the Panthers clinched a playoff spot despite losing last night. Then, Juju is in the studio for another episode of Wake & Take to take your calls and have some fun. Finally, Sarah Spain and Charlotte Wilder join Pablo Torre for some sharing and telling. Learn more about your ad choices. Visit megaphone.fm/adchoices

Love doves and plush pups, This Zany Audio Tidbit maintains: if you're raving in order to artificially extend a genocidal starvation campaign of a besieged civilian population, you're raving for the wrong ass reasons. Tangentially, raves don't actually have to be nakedly capitalist enterprises. They can simply be a group of friends with a generator, a pocket of unused and unnoticed land, and a couple subwoofs. Just sayin.Also: f*ck A.I., f*ck A.I.-driven marketing, (ya know what: f*ck marketing marketing, f*ck making your corporation a cult, and f*ck stupefying cable T.V. w/ it's soma-happy ad breaks), f*ck Grammar software's shiny new A.I. "smart" (see: lazy & dull) content summaries, and f*ck the systematic & zombie-robot degradation & desecration of language and the written word in general.Little Raven pledges right here right now: Never will I dilute and delegitimize my original & organic (and admittedly hectic) content with A. boohiss I. Look, if we wanna go back to hieroglyphics, I'm here for it, but we GOTTA do better than cry/laugh emojis and underlined maximalist numerological encouragements. For f*ck's sake.   Con picardía,little raven kerkawwwTRACKLIST FOR THIS ZATRoyalty Free Inspiring Corporate Background MusicDykotomi - Corvid CrunkMOKKA - SynthwaveVic Mensa - U Mad feat. Ye *FAIR USE: Original Edit - Verbed and Slowed*Support the showSupport My Sponsor:Magic Mind Adaptogenic & Nootropic Elixir 20% off at Checkout!https://magicmind.com/barbarianpod | Use Code: BARBARIANPOD20 If you dig the pod, check out the adjacent video & livestream show Barbarian Yak Fest w/ Dr. Sylvie & Deus ex Machinist on Rokfin: https://rokfin.com/BarbarianYakFestFind me on IG: barbarian_noetics Become a Beloved Patron: patreon.com/noetics (unlock bonus content plus win a Dream Interpretation)Direct Donate on PayPal @barbarian.noetics@proton.me or Cash App@ $BarbarianRavenOne time donation: buymeacoffee.com/noetics.Spread the word and tell a friend. Remember to set the BNP on Auto Download after you subscribe. I appreciate you all.Let's Activate the human spirit! FAIR USE DISCLAIMER:Section 107 of the Copyright Act of 1976 allows for “fair use” for purposes such as criticism, comment, news reporting, teaching, education and research."The good things of prosperity are to be wished; but the good things that belong to adversity are to be admired." - Lucius Annaeus Seneca

Cody, Luke, and Grembo sat down at like 10 at night to get a episode out for this week. Cody had to work, Luke was recovering from working 23 hours the day before, and Grembo was sick on  our normal recording day. This was a fun one that went every where and any where.  

Today we’re here to talk about random topics that are tangentially related to travel. We’ll be discussing destinations, 3d printers, Japanese TV and the Computer History Museum we visited in Silicon…

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: Two Years Community Building, Ten Lessons (Re)Learned, published by Rockwell on August 10, 2023 on The Effective Altruism Forum. Today is my two-year anniversary with EA NYC, where I serve as director. To say I've learned a lot would be a tremendous understatement. The more visible parts of that learning are often technical: who's doing what in which organization, why [niche thing I'd never heard of] is actually really important, what mentorship opportunities exist for people with [these very specific qualities], how to wrangle 100+ people into a group photo and still have everyone visible. (I've gotten super good at that last part!) But I've also learned - or relearned - some much larger life lessons.None of the below lessons are wholly novel, but I think they're worth stating for the broader community. Regardless of where I personally am in five or ten years, I think this is a list I'll return to. The contents are simple but so, so easy to forget. Without further ado, here are ten major lessons I've from my tenure thus far: 1. Many people who want to do good in the world feel alone as a result Through my role with EA NYC, I'm often among people's first touchpoints with the EA community. I constantly have conversations with people who feel deeply unfulfilled in their life and their life's work, with an underlying knowledge they're not currently doing much of meaning. Often, they are in their 30s or 40s. Often, they are - or think they are - the only one in their circles who wants to do something that matters. To them, even just learning the EA community exists feels like a door into a new world, one where they no longer need to feel deeply alone in their desire to do good. There are many people who want to do good and are willing to devote their lives to it, it's just a matter of finding them and helping them believe it's possible. Which leads me to: 2. Extremely impressive people have imposter syndrome I routinely speak with extremely accomplished individuals who I'm so excited to have join the community and have multiple promising routes to impact lying before them. Yet, they profoundly question their abilities. More than once, I've felt quietly intimidated while speaking to someone, only to have them then ask me, "Is there a place for me in EA? Do you think someone like me has anything to bring to the table?" People you would least expect are plagued by self-doubt. People with a range of backgrounds and skill sets are nearly universally poorly calibrated when it comes to their own potential. As a result: 3. People often want "permission" to do good Many people are waiting for an external green light to signal "you can do something that matters." Others, like the SuccessIf advising team, have explained this concept more in-depth than I will here. In a word, people often want an external party to say, "Yes, this is okay to do," before they do it. That external validation or assurance can be a deciding factor in whether or not they take an action. And as community builders and community members, it's our job to provide that permission slip, reassuring others that their contributions matter, their thinking is rational, and they're not alone in this journey.Tangentially, I worry that EA's focus on professionalized channels toward improving the world further fosters "permission culture" in comparison to, for example, grassroots social movements. A job offer should not be a prerequisite to making an impact, and a rejection letter certainly shouldn't stop you from picking up your phone and calling your elected official or volunteering for a human challenge trial. Being able to keep going and keep believing in your ability to have an impact can mean recognizing that: 4. Tempering rejection is a learned skill A lot of my observations above come back to a fear of rejection....

Welcome Friends, to the first episode of ThursdAI recap. If you can't come to the spaces, subscribing is the next best thing. Distilled, most important updates, every week, including testimony and tips and tricks from a panel of experts. Join our community

Let's time travel back to January 29, 2023, with the glorious gem, Amy Dee, who came to stand by Shift as he firmly defends his reputation with the truth. Some liars have threatened Shift's life and livelihood by targeting him with hundreds of triggered fanatics --- this story is very important. Learn about the timeline of Shift's experience getting caught up in Eat Predators' messy “organization” after Alexa Nikolas started what may be the most selfish, inappropriate, and poorly managed book club that has ever existed outside of Yellowjackets season 1.  Amy Dee reminds us that the #metoo movement centralizes around Central Casting, and mentions how irrelevant people can be made relevant by connecting their names in articles to actually important, well-known people and events. Shift covers some anecdotal moments like how Alexa Nikolas' husband randomly left their baby alone with him... In a car... With the keys. And made Shift drive the baby around while he and Alexa Nikolas hung around taking pictures at a protest at Orange County School of the Arts with people like Nomi Abadi, Amanda Peters, and their partners. He also mentions how he was aggressively harassed by a police officer during the time they left him and their child alone.  Shift refers to the bizarre and mysterious exposé website, alexanikolas.net, and how far back some truly alarming accusations about Alexa Nikolas' abuse of others goes. He also reviews how Melanie Veronica inserted her undeserved and erratic #freebritney clout to boost Alexa Nikolas' lies. Tangentially, Shift highlights how long he's been working with media, culture, and movements with a story about taking care of Bella Eiko's baby for 2 weeks in 2014 when Bella went to live stream the events in Ferguson just after Mike Brown was killed. Can Alexa Nikolas project a lie that shines brighter than who Shift really is? Can people play dumb while being smartasses? Can movements ever get their shit together? In all these questions and confusions… we know this much is true… liberal movement "leaders" tend to make themselves the Mean Girls in every room they're in. And… Shift and Amy Dee are committed to facing any foe to help make society more trauma-informed and honest.   How did Shift go from being called a “godsend” to being falsely accused of being a “stalker” by Alexa Nikolas and her husband, her mother, and her cultish fanatical “organization”? Let's get into it.   Hate us or love us? Call us and tell us at 415-343-4420.   Also.... get ready for Amy Dee and Shift's upcoming podcast, Glitch Sesh! A media and culturally-informed history and society focusing on spiritual predators and power abusers who seek to serve themselves at the expense of society and the cultural ramifications and consequences and how social behavior contributes to the erosion of trust in the culture of American society in modern times. Season 1 is all about Britney Spears' circa 2004-2005.               [By the way, we aren't breaking any laws, civil or criminal, by continuing to tell the truth.]

The gang is reflecting on last week's episode and awards show, as one particular Movie Master experienced a physiological and mental shift in the transition from season one into season two. Before getting too introspective, a Model 3 Generative Android invades the set and discussion turns immediately to "M3GAN," the absurdist horror-comedy-musical from director Gerard Johnstone. Tangentially, a discussion erupts on if Johnny Depp was cursed by a witch at some point to relegate him to a lifetime of needing to portray himself as "a rockin' dude" in civilian life. What is "guy service?" Tom Hanks' "A Man Called Otto" is up next and nobody seems grumpy about it. Did you catch the Chet Hanks Easter egg? Was his own father even aware of it? How does this movie compare to CM Punk's movie about buying an old house that ejaculates? The gang considers all angles, with one Movie Masters prepared to declare one character his "MILF of the Year." Welcome to Year Two. --- Support this podcast: https://podcasters.spotify.com/pod/show/rmmu/support

 Hi! How are you? I'm good, how are you? We're back after a mextended hiatus and we have tons of excuses. This week el Sooper talks about his surprise trip to Buffalo and Jess talks about scaring herself for Halloween! What a weirdo. We have a Halloween decoration update and we tear up the argument surrounding Elon Musk buying up Twitter and forcing the bluechecks to pay him money! ALSO how he universe escrewed el sooper and how always has to say ackshooally on the slave statistics! That's sad! ALSo we talk about fentanyl candy and marijuana candy and people failing to make jokes in the papillondemonuium! WOW it's jam packed this week!! Hope you enjoy it, go listen now!! 

The Russian invasion of Ukraine is giving people brain worms. Multiple terrible reports, citing oSiNt aNaLyStS, have recently been released and grossly overexaggerated the risk of nuclear weapons use around Ukraine. These reports, particularly about the "nuclear weapons convoy headed towards Ukraine," don't help anyone and just add noise to a chaotic narrative.  Jeffrey and Aaron take a knife to bad analysis, and muse on what deterrence actually means to the people living under it.     Tangentially related, Superproducer Scott is so excited to use this opening again, a year after its last use.    Support us over at Patreon.com/acwpodcast!

Dario Vacirca (pictured) is foremost an artist, but he is an agitator and someone concerned, in a broad sense, about the welfare of people and sees their best interests, and society's generally, being served through the acceptance and application of an unconditional Universal Basic Income. Dario is simply a good bloke. He was one of the many speakers who informed and entertained those who attended, in person and virtually, the annual Universal Basic Income Earth Network 2022 Congress in Brisbane over three days from Monday, September 26. Dario, who is also a writer, is deeply involved with a tenants association that was critical in saving/protecting the early 20th Century Nicholas Building in central Melbourne - you can read about that in a Melbourne Age story "Creatives shine on in Melbourne's arty heart - with a little help". --- Send in a voice message: https://anchor.fm/robert-mclean/message

On episode 191 I am joined by Mike Maher, breathwork coach and host of one of the most popular breathwork channels on YouTube, Take a Deep Breath. After Mikes marriage ended in 2016, lost and curious, Mike spent a week with Wim Hof after hearing him on the Joe Rogan and Tangentially speaking podcasts. The Ice Man introduced Mike to Ice Baths, Climbing freezing cold mountains in only shorts and of course, breathwork. Mike was obsessed and ended up quitting his corporate job if 15 years and Walked Across Spain for El Camino then went onto traveling then around the world and starting a YouTube channel all about breathing. Mike Maher is now the founder of TAKE A DEEP BREATH, a breathwork channel on YouTube and host of the Breathwork podcast BREATHCAST, Mike has trained as an Oxygen Advantage Instructor & Buteyko Practitioner under Patrick McKeown, Mikes YouTube Channel has over 200 videos dedicated to breathwork, the channel is one of the largest in its field with over 143k subscribers and 19 million views, all of Mikes breathwork content is free and available for people to go and try. In this episode you will hear: 03:30 Take a Deep Breath 05:00 you'd follow Wim Hof into a volcano 09:00 Mike's breath journey 11:00 stress and de-stress 13:00 mentored by the world's breathing experts 15:00 the Oxygen Advantage 19:00 breathwork tips for parents 24:00 terrified of the ocean but goes free-diving 29:00 we breath too fast, shallow and through the wrong hole 32:00 breathing affects the way you think and feel 35:00 the importance of nose breathing 43:00 oxygen and co2 48:00 the power of grace 52:00 where to see Mike live 55:00 try these exercises with us 60:00 the only negativity we need is nature 1:02:30 Mike's heartprint I hope this interview inspires you to take a deep breath. Please do subscribe, leave a little review, and share it with someone you wish to inspire too. Always love Ryan Connect with Mike Websites: https://www.takeadeepbreath.co.uk/ YouTube: https://www.youtube.com/c/TAKEADEEPBREATH IG: https://www.instagram.com/takeadeepbreath.co.uk/ Podcast: https://podcasts.apple.com/gb/podcast/take-a-deep-breath-with-mike-maher/id1519472365 Connect with Always Better than Yesterday Website: www.abty.co.uk Instagram: www.instagram.com/alwaysbetterthanyesterdayuk TikTok: www.tiktok.com/@abty_uk LinkedIn: www.linkedin.com/company/abty Discord: https://discord.gg/Apm3Ja465j Facebook Community: www.facebook.com/groups/weareABTY Thank you to our friends at Elevate OM, proud supporters of the Always Better than Yesterday Interview Sessions. Head to www.elevateom.com for Online Marketing & Web Design services that are affordable, bespoke & awesome. Please email your questions and comments to podcast@abty.co.uk

Join us and Zack answers the questions nobody thought to ask about 1981's steamy thriller, Body Heat.  We try to figure out who this JA Preston guy is and should we know him.  Tangentially from there we figure out that Kim Zimmer "Mary Ann Simpson" has been in almost 2500 episodes of TV entertainment.  We hit the career of Ted Danson and the unusual slow burn that was Cheers. We take a trip down Forbidden Cinema True Crime Lane discussing the history of forensics and whether it would matter how much DNA was left behind in the film.  We also look at Florida's laws on sex.  As per usual, when we look at laws, things are way too recent for our liking. We discuss the wild release schedule of 1981 where there were huge, important, blockbusters coming out every week. Guys, there is another safe in this one.  We dig into the Observer Reporter newspaper from western Pennsylvania.  This time it is in a sunken luxury liner.  Spoiler alert, it is full of pointless crap like all the others.  Also in Forbidden Print Corner we look at the September 1980 issue of Playboy that Ted Danson was reading in the film.  There is some fun stuff, some weird stuff, some stuff that maybe could be sexy, but the first article that jumps off the page is about the promising future of model/actress Dorothy Stratten.  Unfortunately we get back to Forbidden True Crime Lane again.

Andy's enthusiasm for Sir Paul McCartney's live stream is infectious. Your hosts check up on their Nexus Q auctions before getting into the week's biggest tangential news: there might be ads coming to your Lock Screen. We'll also discuss Google's new policies to protect your health-related search queries and tell you a tale of YouTube's latest folly.

Andy's enthusiasm for Sir Paul McCartney's live stream is infectious. Your hosts check up on their Nexus Q auctions before getting into the week's biggest tangential news: there might be ads coming to your Lock Screen. We'll also discuss Google's new policies to protect your health-related search queries and tell you a tale of YouTube's latest folly.

Welcome back welcome back! This week AP and Jay discuss respectability politics in relation to how black people are viewed in the media (yes it's TANGENTIALLY related to The Slap but it's worth a listen). In AP's second installment of Into the Sound Booth we deep dive into Lucky Daye's discography and AP's experience seeing Lucky Daye live in Philly.Keep it real catch y'all on the flipside! Instagram - @APandJayShowTwitter - @APandJayShowTikTok - @APandJayShowYouTube - The AP and Jay ShowEmail us your stuff! - theapandjay@gmail.comMusic by Agha JahangirAnimations by Jaydin HillSupport the show! (https://www.patreon.com/APandJayShow)Support the show

This week we've got a list of unsettling doppelgänger encounters (including the very weird story of Emilie Sagée), and New Orleans' infamous Gardette-LaPrete House, aka the Sultan's Palace. Twitter - ghostsnheauxsInstagram - ghosts_n_heauxsFacebook - GhostsnHeauxsPodcastAnd don't forget to send your stories to ghostsnheauxs@gmail.com

25 March 2022. the restoration project www.restoresby.org Hosts: Josh James (pastor) and Tessa Stultz (graphic designer/muralist/Enneagram 4/creative who likes Phoebe Bridgers)

#290: Lindsey Ward 4 -- Discussing a Bunch of Random Topics Tangentially Related to Adventure! by Chris Ward

The Jokes On You girls are 4/4 with 2022 episodes and this week we're SERVING FACE… In this episode, we run the gamut of makeup experiences. From eyebrow mistakes to lips with no liner, we discuss it all! Talley was in the mall waxing people's eyebrows clean tf off, Mel was 13 with a mustache, and apparently, your age can be guessed by how you apply your highlight???? Make sure you live-tweet using the official #jokesonyoupod hashtag. Thank you for your continued support! Like, Share, & Comment!

Maggi and I walk the dogs while chatting about the podcast.

    This week we bring 2021 to a close with a three pack of movies that are firmly winter holiday adjacent.      Christmas Eve 1918, a lawyer comes to visit Mrs. Allen and her three children. He brings an amazing offer that will get them out of not their squalid apartment and give them a chance to improve their lives greatly. That is, if they don't mind a few ghosts. Before they can say some cockney rhyming slang two of the kids are off on a time leaping adventure that will change their lives forever. Just don't think of The Amazing Mr. Blunden and his paradoxes.     After a month as classifieds editor at the Los Angeles Eye and finding that she has been sleeping with the wrong reporter to get a career boost, wannabe reporter Kim takes matters into her own hands and, without editorial sanction, begins to look into a woman's strange death by spontaneous human combustion. At her very first stop, she becomes the target of a coven of lesbian witches. Crammed full of ideas cut from a previous feature, cult hero Brian Yuzna brings a tale that appropriately hates everyone but loves giant cockroaches. Who will survive Silent Night, Deadly Night 4: Initiation?     Three odysseys across LA. Sean Baker's raw and up close ground level view of a distinctive and specific sex-trade subculture. Anchored by three phenomenal central performances and filmed with bleeding edge technique and stuffed with style, Tangerine.     All that and Kevin get serenaded, Dave wonders if Killer Santa was inside him all alone, and Tyler learns the true meaning of Life Day. Join us, won't you?Episode 237- Tangentially Xmas

My guest is Tyler Aaron Johnson. He's a former Division I student-athlete at Nicholls State University. He played a big role on a defensive front that led the nation in sacks and tackles for loss in 2017 & 2018. In Taylor's senior season, they won the 2018 Southland Conference Championship!Tyler & I first met when I was invited to speak to their football team in 2018. Since then, he's become part of my one-on-one coaching program, which he says has provided invaluable insight on his journey to F.I.R.E (Financial Independence, Retire Early).He's a recent grad of Medical Sales College in Dallas, TX. And in recent weeks, he's landed a job in the cardiac division of an industry-leading company.How 'bout that? Just landed his first "real-world" job and already he's fully aware of FIRE.Don't bet against this dude getting to FIRE. Fast. He'll continue to keep his expenses low even once big paychecks start rolling in. That's when he'll start saving & investing a large portion of his income.In this episode, we discuss the importance of "not letting a bad play boil over into a bad day." It's a quote he got from a good football coach. He said coaches will scold you for a bad play, but they did not want you to let a bad play roll over into the next play.Tangentially, Tyler says just because you're not doing well in one aspect of life doesn't mean you're a failure. It just means you have something you need to work on. So keep persisting, be diligent, and compartmentalize.We also discuss the peace that comes from finding joy (vs. chasing happiness). Tyler says happiness is important, but it's a fleeting emotion based on where you are and who's around you at the time.Joy, on the other hand, is a state of being. It's knowing your good days are going to be better than your bad days. He believes living with this disposition comes from God, and says other people call it "zen," adding, "It's something you can definitely work toward."Excellent discussion with a young guest I'm proud to mentor. Hope you enjoy this episode as much as we did!

The word “cloud” is often uttered up in an almost reverent tone by anyone even tangentially affiliated with the IT world. A big reason for this is because cloud computing has been a tremendous boon for all manner of institutions. Getting away from on-prem servers has reduced cost and increased the speed at which organizations operate as well as the amount of data and applications that can be used to add value. But there is a tremendous amount of complexity in the cloud. With so many developers working in the cloud, there are also many potential access points and, therefore, security vulnerabilities. Ami Luttwak, the Co-founder and CTO of Wiz, explains how cloud complexity increases risks to security.Main TakeawaysThe Promise and Problem With the Cloud: Use of the cloud can add value to organizations. For instance, the cloud can potentially decrease cost and promote efficiency. It also adds complexity and possible access points. For bad actors, this sort of complexity creates openings to infiltrate systems in order to achieve their malevolent ends.Asking the Question Differently: To innovate, sometimes it's a matter of just asking a question differently. Also, asking the question simply can be helpful too. That said, it may only appear to be an elemental question after it has actually been answered. Wiz asked the basic question: are your cloud databases exposed? Solving this problem has allowed the company to make an impact in cloud security.MVP Plus Scale: In startup circles, it makes sense to get an MVP out ASAP. Luttwak suggests that startups must create MVPs that also have the capacity to scale. If they do so, they will save time and put their companies in a better position down the line.IT Visionaries is brought to you by the Salesforce Platform - the #1 cloud platform for digital transformation of every experience. Build connected experiences, empower every employee, and deliver continuous innovation - with the customer at the center of everything you do. Learn more at salesforce.com/platform

Episode Summary:Why Cannabis Stocks Are Trading HigherElon Musk takes a shot at Bernie Sanders$QSR Restaraunt Brands purchases Firehouse SubsGuests:Matt Hammond, IPO Warriors 10:00https://www.Ipowarriors.comTwitter: https://twitter.com/warrioripoCybin CYBN CEO Doug Drysdale 48:00Jake Wujastyk, Co-Founder, TrendSpider 62:00Twitter: https://twitter.com/Trendspider_Jhttps://www.trendspider.com Enter promo code BZ25 to get 25%Chris Capre  https://2ndskiesforex.com/ 93:00Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited TranscriptHappy Monday, everybody, the markets are back open. Let us know in the chat. What y'all are watching and trading today. A B here, Spencer with me as always Spencer, how are we doing today?We're doing well. We're doing well. Uh, how do we want on the new intro? I saw I saw a new intro. I think it, I think it's, it's part of the way there. I don't think it's all the way there. Do you want to run with the, uh, part of the way there and new intro, the old intro, or just roll? Why don't we roll? No intro today.Let's just rolling. No intro. This is the show it is starting actually already has started. Somy question may be is what has taken a bigger haircut? My head or my portfolio? I don't know. I mean, hopefully your, your portfolio is not taking too big of a haircut. Considering cannabis stocks are all up nicely today. They are, um, using some of my handy-dandy metrics out of the top five trending tickers on social media.So Reddit, Twitter, all the whole investing sphere, two out of the top five trending stocks are in the cannabis space. Spend six. Guess what those two stocks are. Okay. Okay. Without looking two of the top five trending, trending on social media stocks today, um, Uh, are they both stocks? Are any of them? ETS?Are they both? Stocks is one of them kind of be growth? Nope. Damn. Okay. Oh, for one is one of them Grogan. Nope. One for two. Okay. Is one of them, are they both? Are they OTC? No. Uh huh. A Tilray would be the third, the third guest. So Ray's one of them. I see the other one in the chat sundial. Yep. Tiller and sundial are two of the top five trending tickers.Uh, the non-cannabis stocks in that top five are Tesla, Nvidia and Vivian. Okay. So, um, we're, we're going to talk about all this today. Let's talk about everything so that, you know, Tilray and the rest of the cannabis stocks are up on the news that the Republicans are bringing forth a bill to legalize cannabis in the United States.Um, Spencer, do you know anything more about that bill? Uh, another due to present it today, uh, I got to give the, give it to the Republicans. They just basically just hijacked and one of the key issues on the democratic platform and said, well, we'll take that. Thank you very much. Yeah. They're basically saying, Hey, if you guys aren't going to do this, we will and we'll get the credit for it because it's one of those measures that's widely popular throughout the, um, you know, all voters in the United States.So it's, it's. You know, one of those things that'll be a good, easy political win for the Republican so we can get it through which we will see. Um, but either way, I mean, even if they don't, because then if the Democrats step in and have problems with the bill and they can say, oh, Hey look, it's the Democrats holding up, um, you know, legalizing cannabis, which again is something that's, that's very popular.Um, solar up saying, yeah, they, they want to legalize the profits, but we'll see. I mean, I assume there will be, you know, we'll see if, if there can be bipartisan, um, support and work done on the bill. I'm not very bullish on that. We should probably save this discussion for later on, on this show, because we're going to have a cannabis related CEO, uh, on Doug Drysdale was a CEO of Simon to your CYB N related to cannabis, uh, kind of right.Tangentially. It's the same idea of legalizing a drug. It's the same idea, uh, surviving, um, psychedelics are a few years behind cannabis. Um, in everything, right? In terms of regulatory changes, legalization and capital markets a few years on cannabis. So, um, I would be curious to get Doug's thoughts on all this, but I, that being said, speaking of guests, uh, we skipped it on here.Cause our first guest will be on here joining in, in a minute or so. Um, Matt Hamon from IPO warriors is going to recap, uh, last week in IPO lane and preview what is to come this week in IPO's. I'd be curious to hear how Matt played a reveal. And last week I mentioned our Drysdale, uh, from Simon. That'll be at 1245.Love Jake, would you ask Dick from transporter on the show one and Chris Capri from seconds guys trading on the show at one 30. So do as a favor, hit that like button, tell your friends, tell your neighbors, tell your friends, neighbors, dog. And, uh, we can get ourselves off to a good show today. Good start to the week.So like you said, markets in the green, at least last I checked I'm in the green. You're in the green row on the green. What about Dylan? What about Igor? What about bear for one of the chats? I actually took a little thump ski it's in the red right now, but it looks like it's coming back up. I don't know.Yeah, I know it dropped about a quarter for cent out of nowhere at around 11:40 AM Eastern. So that's interesting that 20 minutes ago, I know we'll keep an eye on that. Uh, Q Q kind of same thing, but yeah, Spencer, so big headline over the weekend was of course, Elon Musk on Twitter, uh, you know, took a shot at Bernie Sanders, which some people love.Some people didn't love. Uh, but, but overall, the, the bigger story here is just Tesla's price action in the last week. Um, the stock let's pull up a chart so we can wait, I'll pull my, while you talk, this stock is down more than 15% in the last week. So we're used to seeing Tesla stock, you know, take rips up.Of course, nothing goes straight up. There will be dips along the way, but usually with Tesla, those are followed by bigger rips. The question is, will we get that bigger rip or what will we see the weakness continue? And Tesla's chart. What is test on a bear market? Is that what this is? Where, uh, let me, I'm going on a different chart here by standard definition of going down 20% or more, um, from its all time highs yesterday in a bear market.Oh my God. Yeah. I mean, we, like I said, we will see, cause a lot of times these dips are followed by bigger rips. And that will be the question with Tesla stock. I think this week will be very, very important to see, um, who knows by the end of the week, we could be back at all time highs at around 1200 or we could come all the way back down to 800.So anyone out there that's trading Tesla, let me know how you are trading it in the chat. I'm very curious, you know, are you, are you playing it with the options? Are you buying the stock? Are you buying the dip? Um, let us know what you think about Tesla, because right now it just seems like there's a lot of wins being taken out of the sale.Of course, Elon Musk has a lot of different reasons to sell stock. Part of it is that if he doesn't sell any now than a lot of his options can expire, um, without him exercising them because you can only exercise so many each quarter. So if he doesn't start doing it now, um, he literally needs money to pay the taxes, right.And, and like, and she doesn't have the money they're there. They're the adage goes, there are a bunch of reasons to sell a stock, um, paying taxes, being one of them. There are only a few reasons to buy one reason to buy. There's only one reason. One reason to buy. Well, yeah, we'll say there's only one reason buy what's the other reason using the one, one reason why talking to.Well, if you're like a inset. Yeah. But if you're say short a stock, you need to buy it to cover. You know, there, there are multiple reasons you can buy something. If you're an insider, like Elon Musk is, and you're going to buy the stock. There really is only one reason because you think it's going higher.There are a multitude of reasons is why you would want to sell a stock. But I think regardless of what that reason is for Elan, um, for Tesla, shareholders and Tesla fans in general, seen him sell stock is a bear sign. So we shall see. But right now, Tesla down about 4% on the day, continuing, uh, uh, bear trend for the stock, which we haven't said in a while.So, um, again, let us know in the chat, how you guys are trading it. Um, etc. Same Tesla just approved to sell electricity and sexist. We'll see if that can be a catalyst for the stock, but who knows, Dave is saying he's buying the dip every time it's on sale. So it has been proven right? Time and time again, buying the dip always works.Isn't that the rule, it always works except in some stocks. Yep. So Spencer, before we get to Matt Hammond, we've got one more headline, this one in the restaurant space. Um, so if you're a, you know, a fan of fast food chains, whatever this may interest you, uh, QSR. Yeah. We know it. Owners of burger king and Timmy hoes over owners of burger king, Tim Horton's, Popeye's just acquired another brand today and an all cash deal, a sandwich.Franchise, you know which one that is Spencer? I, well, I saw the headline, it was firehouse subs. It was $5, billion dollars for firehouse. So some expensive subs. So that just goes to show you guys, if you open a sub shop and you do well and you franchise it out a little bit, you can sell it for a billion dollars.A restaurant brands goes out, buys, firehouse, and then a $1 billion cash meal, uh, you know, will, it looks like the markets like the move for QSR up about a percent, but nothing crazy. So we will see how prior house is able to impact, uh, restaurant brands is, you know, revenue, balance sheet overall, but just some, just some headlines in the restaurant space.That is, that is a, those are some expensive stuff. That's all I'll say by Shelly, congrats to the firehouse subs, seriously, that company donates a portion of their profits to firehouses. So, so congrats to them. Great job. Yeah. Who knows? Maybe they'll stop that. Now that they're under new ownership. I doubt it.I hope not. Um, Shelly pointed out another headline in the, in the restaurant, fast food space. So McDonald's announced a partnership is still relevant. It's about to be holiday season. So every time Mariah Carey she's and it's here, it's here. It makes it come back every year around Christmas time. So we've seen, McDonald's do this with a few other artists have, have, you know, deals.They have one with BTS the popular, uh, K-pop Korean pop band. They have one with Travis Scott. Um, so now they're doing the same with Mariah K. Yeah, I know. So anyway, uh, so we know it's approaching Mariah Carey's season. Uh that's that's in a couple of weeks though. Uh, you know what season is now? It's Manhattan season.It's IPO season. Let's get mad at him and all the total talks to my POS. Is he at? Nah. Hey, I'm doing great. How are you guys doing it is IPO season. Um, we had an off season there and, uh, some, some pretty big ones. So, uh, okay, excellent. I can't wait to hear how you put revealed last week. So here you go. I told you I was going to watch for Vivian, but it did play out what we'll get to that one in a second.Um, first thing I wanted to say is thanks to everybody who contributed to the fundraising campaign. I said, I wanted to get some better streaming equipment. I want to live stream. Some IPOs have been talking with Benzinga they've at least indicated. Maybe we'll do a little bit more switching out to watching some of these actually go live.I think it would have been pretty fun to watch some of what ribbon did, uh, you guys have, you know, talking to Rowan, he's going to kick me out some gear as well. Uh, but we, uh, we got $2,000 in under one week. Um, and I really appreciate all the support. Some of the things I'm gonna use that for is improving the presentation quality of these, uh, kind of weekly shows.I would like to do some live streaming of the IPO debuts. And if time allows, I will do some video breakdowns of the IPO as before, uh, before they go live. Um, really appreciate that. It's not too late to contribute more, I'll buy more stuff and, um, you know, improve things even better. You should have some equipment on the way, man.Yes. So I've heard and I, and I'll ask for some, if you guys have some t-shirts or stuff, I'll wear those on the, on the show and with what I'm doing. So, you know, uh, yeah. Yeah. Well say what's on your waist. Some schwag sweats. Okay. So we actually had a lot of really good ones. Um, we talked about sent a one off 25%.We'll just run through these real quick. I didn't like this as a play. I don't generally like, uh, anything that dumps like that anyway, uh, dumped off the debut. If you did say, Hey, wait, this is below the IPO price. It's dip this far. How, you know, how bad could it get? Um, you know, you were rewarded not just with a retracement up to , which is a lot of times all that we see.Um, but if you held through that and said, okay, well, I'll give this some room to run. Uh, it just for no real reason blew up, uh, head up to 2250. And you know, one of the things about trading is you're looking for, uh, stocks with catalysts. You're looking for volatility. That's what you're looking for in day trading.And that's why I like IPO is not, all of them are going to do this. Uh, but if you have, if you like this company, I guess a lot of people do like this company, um, you know, your catalyst is, Hey, it's IP. Uh, the momentum, the volatility, the volume are all going to be about as high as you can ask for on the days that they IPO, which is what make these attractive targets for a day traders.So St was one society pass. If you remember last week, I said, Hey, this kind of, you know, a crappy, uh, Asian e-commerce ish, you know, S IPO that really looks sort of weird with a pretty low float. This could be a stealth IPO. Um, I tried to get in on this, and unfortunately we will hit the indication price rate before it debuted.So I had mindset at 1350 and it debuted at 1550 and then dropped to 15. So if I had been a little bit more aggressive out of caught this ride from 15 through four halts, top tier, like 42 or something, um, came back here around 30 and we see these just run the same pattern, ran up to 52. Uh, the next morning ran up to 70 and we saw these with thanks.Uh, C pop, um, TRS. Why do you suppose that is? I don't know if we've ever, if I've ever acted that before. Yeah. So there's different theories about this. Um, Having talked about it with a bunch of people and putting our heads together. The thing that makes the most sense to me is that, you know, whoever's buying it way up here is not trying to buy low and sell high.They're almost like trying to buy high and sell low, um, or really just buy high and not give a crap. I was going to say, buy high and sell higher. I thought, well, I mean, who's buying, I mean, they are pushing this up through halts on day two, you know, and somebody paid somebody up at $60 for a garbage company.I mean, we saw EJH was one of them that did this and it's like a cleaning company in China. Uh, w and w which spiked yesterday through some Holtz off some random, I mean, they're, they're low float to begin with. They tend to try to do things to deter us from seeing them or for wanting to play them.They're so bad that, um, you know, no one in their right mind is going to pay this thing. The IPO price was a $99, you know, who is going to say, okay, well, this company has no revenue or barely any revenues. The, uh, the, the platforms that they run are garbage. Uh they're they're just losing money. You know, who's going to pay $15.It's so bad that it's good. It's so bad. That it's good. That's what I think. I know. I mean, my, my answer and for this until proven otherwise is that they're all, they all have ties to China. I mean, we saw FCU. The was a uplifting. They all have a similar on underwriters. This one was max. We've seen a lot of them that were, uh, boasted securities.We saw a bunch that were network one financial Sutter, and a lot of these companies have done IPOs together. They've co-written, um, you know, been the co-writers on IPOs as the underwriters. So there's sort of like, they must happen my theory and they use the same lawyers and they have, uh, my opinion is that they're helping Chinese and other wealthy Asians, especially Chinese follow money out of China.So if you have a whole bunch of money in a bank account in China, and you're trying to get it into Hong Kong or Singapore or into the Western markets, what you can do is you can issue shares somehow out to, you know, if you can hand shares cheaply to your cousin or your uncle or some affiliated partner outside of China then, and just tell them, Hey, I will control the, you know, control it, just control the float.And I will buy, you know, as much of this stuff as I can, uh, with this say $200 million I have in a bank account here in China, you know, that money as I buy those shares that no one else has no. You know, who else is participating in this market? Not a lot of people. So if I'm the only one buying your shares, I'm basically giving you that money and moving that money from China to, um, you know, to the west.And I talked about last week, pets, pets was one that I had called out a month ago and sent out to my newsletter when it was about a dollar 30 or a dollar for. Because they had the same underwriter do a direct offering of 30 million shares basically at about 60 or came out to about 30 cents a share when you factored out the warrants and the profits.And you're like, well, that should just sink the share price, but it didn't, it did a little bit, um, but it came right back up and now it's up at $6. You know, it was at $4 when we talked about it on the show last week. So why are they doing this? Why is hoodie H UDI? Why has that got to $45 in the last, you know, few months?Why has, why did TRX go all the way up to a hundred dollars? And then in one day lost 90% of its value with, you know, with no headline, no new news, no nothing. Um, why does, uh, w and w sometimes randomly pop, why do, uh, you know, why do these go well? Because in my opinion, they're moving money. They're using these as vehicles to get money out of Asia and into, you know, Western markets and the seat after, after this happened, I went back and said, geez, you know, Y you know, what, what did I miss here to not make me just put my limit order at like 16 or 20 for that matter?And I went back and I looked up, the CEO is, you know, extensive experience doing startups in Shanghai. The CFO, you know, is Chinese. So, um, you know, there are hands FCU V when we look back at it, we said, oh, we had our eye on it. And it took a day before they ran it from like five or $6, all the way to 25. Uh, in one day after their up listing, and then now it's come way back down, but what was up there?Oh, the whole, like the only three employees are all very, very Chinese as in, they don't even have American alias names. They're Chinese engineers. So this tie back to China, and that makes sense if you're a wealthy Chinese person with tons of money in China right now, given what, you know, president Xi is doing over there, he is basically cracking down on the wealthy and if I was a rich person, uh, or a rich person in China, more specifically, I would be trying to get my money out of there too.And it's not easy to do that. So even if you're paying a 30, 20, or 30% premium on the shares that maybe get bought out or sold by other people, um, and this is an effective way to, and it's not the first time that the stock market has been used as a way to funnel cash out of a country. The Russians were doing this in the nineties.Um, and that's, that's the only answer that I have. How does, you know, how do completely garbage companies make insane runs? Uh, that all of a sudden, I mean, this one's still kind of holding on, but I don't, it's, it's, it's nowhere near any reasonable valuation and all of these tend to Peter out, or they all do Peter out eventually.And when I look at pets and what they're doing there, I'm just like, okay, I'll just, I sold enough. You know, I bought in at basically a dollar 20 and I sold enough when I reached eight on one of these days where it gets by. That I've already paid for my position. And now I can just sit back and if they run it, I think they're still running it because it hasn't fallen out yet.And when it does fair enough, fair enough. Anyway, I try to call these out when I I've made huge profits on some of these, uh, I made 30,000, $33,000 on a thousand shares of TRX. When it debuted, it went opened at 17, went into a three-hour hall and opened up again at $50. You know, so if you can spot these and you take kind of a, okay, well, you know, I'll, I'll give it a shot approach to it.I mean, the, the returns have been massive. UTME that was another one. Anyway, back to the more traditional kind of fun and boring ones that are also profitable. If you play them right. Expensify, we said we liked, uh, we got in here at the debut. I do like taking a $2 profit rate off the run. Um, it's sort of, kind of the easiest, I would say two hours and trading is defined a good, you know, a good company with these guys had to have a positive baseline financials.They're somewhat brand recognized the float wasn't too big and it gave you exactly what you expected right off the debut. So you buy a thousand shares, get in it, you know, say 39 75, sell it at 42. That's like a really pretty comfortable, easy 5% win, uh, right off the bat. Uh, the market. Wasn't really rewarding.These IPO's on day one, the way that we've seen maybe three or four weeks ago. So this one pulled back a bit. You could try to double dip. I generally don't do that. Uh, but where the real money was in these plays and I'm taking notes for kind of the next set of, uh, of IPOs is a, these day two runs. Uh, this one actually touched $50 today.You talked about that a lot. So especially for brand name IPO's, a lot of people are starting to kind of come into the IPO. I'd say that the number of followers I've got has been much higher over the last two weeks than the, you know, the previous six months. And I think a lot of people are keying in on it and it's, in some ways you have to adjust because if everybody's buying in pre debut, that's less demand once it actually goes live.But a lot of people are kind of catching that overnight media cycle where the, you know, the headlines say, you know, Expensify pops 50% on its debut, and they're not talking about this move. They're talking about the IPO price was like 18, and then it debuted at I. Yeah, I, and you know it, wherever you can do the same thing.I I'm hoping we can get to that because I, I was taken aback at the ferociousness of the day to run in green river. And I guess I shouldn't have been, but I was cause. Because it seemed to go straight down, skip through the, to that one that, or, you know, black ways, again, $2 taker just right on the debut, $2 in your out hole, you know, and you can hold these and they come back in.I wanted to show you one thing about holding IPOs. And again, I don't consider playing a debut to be super risky is, um, okay. People who played this cocoa water, uh, you guys were talking about it this morning and that was a, it was actually not a good debut play. Uh, and which is why, you know, when people ask me, oh, what do you think of this company?I'll say, well, you know, for a long-term position, I don't, I wouldn't suggest buying debut. Um, but you do want to start watching it then, because then you kind of know where it's ranges, where it trends. But if he did say, oh no, this one's going to do great. Uh, everyone loves it. Uh, I'm gonna, I'm going to buy the debut and you got stuck in it and you didn't get any kind of day to run.I've held IPO debuts for, you know, usually it's about a month before you're gonna see what it's going to turn around or not. And the catalyst you're looking for after the debut is the end of the media. Um, or the, uh, press release kind of silence, period. I guess they call it. And the first earnings report.Now, these guys happen to come in with a very strong earnings report. And if you had liked this company enough to buy the debut and you have the conviction to buy it there, why not hold it here? See what it does. And. You know, today you finally gotten, you know, today was the first day after a month, basically a trading that you got an opportunity to take your profits.Do you stop there? Probably I do. If I'm holding a bag and I'm given the opportunity to cut it for a non loss, I'm out, um, very rarely will I hold longer than a day to have it come back and then say, no, I'm going to get greedy. Uh, that's only hurt me when I've tried to be pigs, get slaughtered anyway, a vaccine city by the halt, uh, by the debut, this had a ton of buzz, low float, sell the halt right there.Easy as pie and take your profits. Say thank you. Uh, derm debut below. Where did I put ribbon? Okay. I would love your thoughts here. Cause it seemed like he just went straight down and I, and I want to pull it up on, um, give me a second. I'll pull it up and we can look at the, uh, the chart here. So ravines pretty much exactly what I said.It would do two things. One, I had just taken a win on a. What was it? The, uh, Backblaze or the one before that was earlier in the day and after take a win off and just be like, okay, that's the one I wanted. I am, you know, I can try to keep playing more, but I ended up starting to make bad decisions and, uh, try to control against that.Uh, Ratheon was on one hand, a great a, you know, I mean, how much more social media buzz and momentum could you ask for than any V play when Tesla just broke a thousand and it had a lot of other great, uh, you know, I had a lot of good storylines to it. The Amazon deal it's Ford as an investor, um, but had a huge float and I don't like huge floats the floats 153 million shares.And we S I think I said on the show that it reminded me a bit of snowflake and Coinbase. And my, and my, uh, theory was that we'd get about 10, 15 minutes of upward momentum and then correction, which is exactly what we saw. And for me, I'm not long EVs. I still think that, you know, at some point in the not so distant future, the market is going to realize that selling vehicles is only so profitable that not everybody, um, is just going to buy one model.And, uh, you know, they got supply chain issues. It's just the valuations on these don't line up with what automobiles have traditionally sold for. And I think eventually we see that I don't know when it's going to happen. Clearly it wasn't this week. Um, w I did, you know, so I was in the gym and I was watching, you know, ticker in between sets.And when I saw it kind of come here, I think I'd got off my run and it was a hundred. I thought I already missed that dip here, but, you know, maybe that's the, maybe that's the place to buy for the day to media run, because this is clearly going to get a ton of media hype. And then it started moving down again.And I kind of said, um, maybe, you know, maybe it's not as hard as I thought it was, but clearly if you saw this and bought in for the day too, and I mean, you're in an excellent position. It's a one, I mean, Clayton has pointed out. I, I, I, I lost sight of it. Yeah. I mean, w w w we did, we hit one 50. Yeah, we did.We hit one 50. Holy cow. Holy moly. So if I had pulled that day, you know, that day one trigger down here, I would have sold it, maybe one 20. Anyway, I just don't like I went through over the weekend. I went through and I really needed to do a bit of a self evaluation of Metro. And I make so much more on IPO and sort of like, you know, I like to stack guys like Mitch, uh, and the, you know, the blanking on his name there, the guy that does the, the selection.I mentioned Chris. So they have, I mean, the, the, the, the amount of money that they've made for traders in their spec, like the spec catalyst to me, is kind of similar to the IPO. It's like, you know, what's coming up, you know, that it's going to have a merger vote, you know, that it's going to DCE back and become, you know, a name and that's going to be immediate, you know, the next door.That was pretty obvious media catalyst. And I went from like 11 to 18 in one day. Uh, so these, you know, I like specs and IPO's because no, where, you know, it's so easy to time what's going to happen with everything else in FDA announcement, that's going to come off market. Or, you know, whoever gets the news first is going to get it.And some, a spike right up, you know, you don't know that that's coming or these other plays. And I looked back and I just I've done so well on these words, swing trades, where you're trying to find the bottom and, you know, read the trend and you have to wait, you know, a long time to make your money.Whereas an IPO, I want to make money in like one or two days at keep my, you know, my money in cash. You know, the market can crash one day and I'm not exposed. And I'm just in a, to me, it's it fits my style. Uh, if you can't sit there and play these in real time, would your screen all day, you know, then it's not a great trade.If you're good at day trading and reading charts and all that stuff, you know, maybe that's better for you. I'm not. Uh, I ended up, you know, with a long list of bags, waiting for them to turn around. I like to get in, get out, hold for one or two days, maybe three, if I really think it's hot and maybe I should have read this one a little bit more.It's also, is it a price where it could come down a lot more as well? So, um, never been great with EVs, but we'll see this week, there's a lesson to take forward from this week that maybe we will, uh, be able to catch. So, um, let's, uh, jump through affinity. I think we've recovered, uh, covered those. So this week's featured IPOs.Do you want to say anything more about ribbon? No. I was just curious to hear how you played it. I mean, I sorta lost sight of it today, so I was surprised to see it at one 50. I realistic. I felt like going in, we were, we were Jones in for, for a rock pole on the way that was wrong. That was wrong. Uh, but it just sorta had those vibes near, but Hey, sometimes the obvious place to play.So, uh, what do we have this week? Ooh, she was asking me when I became a speck fan. Uh, the first fact that I really banked money on was, um, what was that? Uh, Nicola. So I've been in SPAC since pretty much the second one. That was it. That was the second big one of this. Yeah, that was yeah. After fan do. And I got FanDuel like the day after it disrespect or not FanDuel or DraftKings drafting.So I got, I got dressed and that was like, I didn't really know what a SPAC was. And I think a lot of his back was that in, in may of 2020, so that put them on the maps, put us up, put us on the map. And since then I've played a TMC Michonne. Uh Chris's you know, uh, I got high on cue. I got, uh, they're they're, they're a handful they've been, they've been pretty good.Uh, and it just, you know, don't get greedy, take your profits and, uh, you know, look for the next one. I'm actually almost always sell out, but by the time I see, you know, 20 to 30% up, I'm just like, yeah. So thanks, bye. You know, and, uh, raise up the cash. And then they run up to like a hundred percent gainers, but that's okay.My room, I have two rules and trading. They are, uh, written here. So I don't forget. They are take like you can't read them, take profits without regret. And don't chase. Those are my two rules. As long as I stick to those, every time I break those and get myself in trouble, when I stick to those rules to do pretty well.You got the calendar. I saw one, the other jumped out to me, but so, so let's run through the boring ones. Sure. Uh, sonar group is not so boring when you consider solar coding for. And they do have, this has sexy all over it. Yeah. And they have, so they don't have any revenues, no point in going over financials, they do have 50 million in customer deposits for their sign-on vehicle.Um, as I understand, those are deposits that, uh, I don't know what the refundability is on those, but when you combine two hot, you know, you're talking about eco solar and Evy and that's, you know, how, how much more do you want there? Right. And you can't put Bitcoin in it's can you, um, so not, yes. Yeah. Right.But you can buy with Bitcoin. That would be the next catalyst. Um, but, uh, yeah. Uh, they, if they mined Bitcoin with the spare solar power, then maybe you could, you could pump this up even more than it is, but this is about as much, um, kind of hype buzzwords. You can cram into something right now. And I got to try this one because, you know,yeah, Wednesday, we don't have any until Wednesday kind of a little bit thinner week. This week, Iris energy. This is a Bitcoin miner. Uh, they don't hold Bitcoin on its balance sheets apparently. But if Bitcoin, how is that possible? Uh, maybe they just sell it right away. I'll on mine and they sell it. Okay.That's something new. I gotta, I gotta research a little bit more, but they do have positive cashflow and operating profit, which leads me to believe that they are selling these, um, And they're basically they're using IPO money to buy more hardware. So if they're successful in mining, why not scale up? Uh, especially when the price of Bitcoin, at least a lot of people believe it's headed to, um, you know, to a hundred thousand.So if the, unless Bitcoin crashes before Wednesday, uh, this looks like a pretty hot play. S D I G, and a couple of the other, all the other Bitcoin IPOs have done pretty well. So 8.27 million shares. That's pretty low float. I like this. Uh, you know, the trend is your friend Bitcoins are trending. So we got my point, right.With all these IPO's. So we've got Wednesday, Thursday, Friday. None of them have priced yet. Right. Do we have an expected w we have the ranges, but we don't have the pricing until, and the pricing can change, especially for the hot ones can change dramatically. Can you give the range on these if you have them?Okay. For, I don't know, they might've pulled as C S E V already. That's too bad. Let me see a Sono price range. 14 to 16. Okay. Um, we've got, uh, IRN 25 to 20. So for the hot ones, we often see them get bumped by, you know, a dollar or two price out of range, a price at the high end and things start pricing at the low end then, unless, you know, if you get a discount to that then, okay.Maybe that's interesting. Uh, in other words, the debut comes live below the IPO price. That's been a pretty safe, uh, play, as it works its way back up to the IPO price, you would expect not a lot of IPO price, uh, buyers are selling, uh, for an immediate loss. So, um, but kind of pricing in the middle that has not been a very good, a sign of strength and I'm generally sitting on the sidelines for those.Okay. Um, but yeah, I mean, solar, Evie, and Bitcoin to lead off the schedule, those, you know, once they should be fun, uh, user testing, this is a platform for companies to test user engagement processes. Uh, maybe it's a good business revenues up 44% last nine months gross profit up 51%. Um, but negative cashflow, negative operating loss, negative income.This is kind of just one of those SAS plays where I've never heard of this company before. It reminds me a little bit of this company was like internet advertising program IAP or something. I don't know the. If you, if there's no brand recognition, they have to be really strong to get, you know, people to come in and buy them.And there's also a sort of odd follow on offering lurking in the, this is not the, it's not a lock of expiration, but they have the right to sell an additional 27 million shares. If the price is 10% above the IPO price, you know, it's something like over 10 days in the previous week or something like that, the point is that the debut price will likely be over 10% to begin with.So if the IPO price on this is, uh, 15 to 17, let's say they debut at 17 or 18, and then it actually debuts at 20. So if they IPO price at 17 or 18 and debut at 20, you already at that 10% level, and then it's, it's think it's a hundred days or something 90 days, then they can, you know, then they can sell them 27 additional shares, which almost doubled, you know, it's more than doubles the float.And I don't really like it when I see those kinds of things just gives me shivers, like remembering what coping had hidden in its, uh, lockup period, which was probably the worst IPO I can recall. Um, playing that was the day was you'd have like 60 or 65 and miss now at 27 and never even gave you like a.Courtesy rebounded any point, really? It just was a downward downward dumpster fires. Alright, super interesting here. Um, res, now this one is, I mean, a similar customer engagement and communication. Revenue's up 2.6% gross profits up 60% again, negative baselines. And unfortunately it comps to Weaver, which last week did not do well on its debut and brace has a higher valuation, but I think it might appeal to more businesses.So I don't know, 8 million shares. It's just, I don't feel super good about these. And given that there are others that I do like more this week, I probably just let these pass. I can't play every single IPO. There are people who have that approach, you know, for them and they really manage those trades.They're better at day trading than I am. They buy on the dip and just hold it for ever sometimes. But, uh, this one to me, both of these sort of user cutting and Braves, both in customer engagement, if user testing, somehow those, well, maybe that changes my opinion on Brays, but I'm looking forward more to this one.It's a sweet garden. Now we talked before about how restaurant chains have done really well on their IPO's. And I kind of include bros in that, uh, you know, in that group because it's a chain. It does well on. You know, on a limited number of locations, the theory being well, if you raise a bunch of money and expand it nationwide, it'll do even better.So this one is like, kind of, I guess they say plant forward, which I read as vegetarian, but I guess they probably have some meat in there somewhere. Maybe they do. I'm a little bit deeper. I'm not a vegetarian, but Hey, you know, everybody wants to go out to eat how they want to. But, uh, interestingly, they acquired this company called spice food and this company looks pretty interesting.They're basically like a robotic powered restaurant system. So you're kind of getting a technology angle on a restaurant chain and given what bros did given what Portillo's did even, uh, F w R G, which is some, you know, breakfast restaurant that I'd never heard of a chain has done, you know, did well off of its date, IPO debut.So these guys are article last week that robot sales like industrial robot sales are at an all time high. I didn't see that. And that, and that kind of makes me feel like this is in alignment with some of the trending topics in the market right now. Okay. So the rebounding out of COVID revenues up 50%, I mean the revenue numbers mean nothing.We've talked about this before. If you're going to compare how a restaurant did for any P you know, the last six months, nine months, 39 weeks, whatever, uh, to the year before we're still making comparisons to. And I just kind of have to throw those out the window, uh, negative cashflow, net income, and operating loss.I don't love though to see that in a restaurant industry, others have been, I think a, you know, Portillo's was, you know, positive and its financials. Um, but I said, I don't want, I'm not going to miss the next chain restaurant play and, uh, bros, Portillo and F WRG. They all did well for IPO's it's 12.5 million shares.It's got healthiness to it. It's got the sort of, and although, you know, Oatley did badly today and beyond meat hasn't done well, there is still a demand for in health forward plant forward eating. And I want to give a, you know, I want to give a restaurant chain, um, you know, I'm going to stick with the trend there and try the rest of the rest.Ha ha healthy food. Alternate is not hot right now though. So, well then maybe we get a reasonable entry price on this as well. All right. That's the glass half full approach. Okay. Fair enough. KinderCare. Yeah, the main thing is just again, so KinderCare learning, um, education centers, blah blah, blah, 1500 locations reopening momentum.They make revenue. This is something this should not be allowed to be a public company. I'm sorry, just to not, no, no. Forget to forget that this should not be a for profit. Like childcare in the, in the U S is so unaffordable. And now we have companies that are going to be publicly traded. They have to answer to investors and the answer to wall street about their stock price and their, their margins and their, and China just made that move a few months ago and killed all the private.This should not, I, this I, that might not be a popular opinion, but I mean, this should not be a publicly traded company. I missed we're talking about childcare, whatever. Just tell us, tell us about the IPO. Ah, yeah. W gross profits are up 3534%, but again, we're talking about comps to lock down, so I can't count much in there.They do have positive baseline financials. So cashflow income operating profit are all positive. So it's a big company. I mean, you're talking about 1500 locations and I mean, we're a capitalist society. If our social different socialistic approach to working, you know, the private market's gonna, you know, is the only, it's our only hope of we can otherwise we're just gonna have, you know, who's going to be the educated future.I mean, I agree with you. I th but we're talking about the holistic approach. We have the socialistic approach to K through 12. It's just pre-K that people versus this is ages six to 12. So this competes with, um, with public school. Okay. Yeah, I do six to 12. I think it's a lot of like preschool and afterschool.I kind of skipped over because I just sort of like, nah, maybe this company is pissing me off next change the subject. All right. Six weeks to 12 years old. Oh, six a week. Wait. Okay. Whatever I, I w oh yeah. Yeah. We've been filling a need there. I have an 18 month year old kid and a child. And, you know, there are days when we would like to just put her in someone else's care if we found someone trustworthy.I bet. All right. Um, no, I love my daughter. I love spending time with her, but it's a lot better. Anyway, uh, Austin gold, this one is sort of like, Hmm, well maybe, uh, it's a gold exploration company in Nevada with corporate offices in Vancouver. Uh, they are revenue, which means they basically just are exploring right now.And the website is horribly lacking. Uh, it looks like something a kind of intern might build as a test project and a web development company. And for me, that's a red flag. I, uh, you know, I mean there's pages where it says like, uh, error content missing on their press releases. Uh, their investor page is basically blank.Um, and since I am a designer developer, I do find that, especially for these sort of low float under the radar IPO's unless I'm looking for it to be terrible. Uh, not having a strong, solid website is sort of like, I don't know how seriously I can take this company if, um, you know, if they don't even have an updated website, uh, I want to I'm with you.One interesting thing though, is that, uh, some people I know who have some knowledge of Nevada and gold mining said that these guys are operating before areas that they're operating in are the right areas to be operating in. Um, and the CEO just last week sold his previous company for $2.8 billion, which was it's really M resources.And he sold it at a, something like a 30, 40% premium to the share price. So Cheryl, you know, shareholders are happy with that. Uh, the float is 3 million shares, but Roth capital is not a particularly loved underwriter. Uh, they must've done something. I still haven't nailed it down, but they have sort of a reputation for screwing, uh, IPO buyers and people tend to avoid them.Um, we've also seen a lot of their, IPO's just seem to get terminally rescheduled and we're up against the clock. We, we, we got, oh, that low. We're on time. Yes. Awesome. That Hammond runs IPO warriors joins us every Monday to run through the weeks late an IPO. And we appreciate that Matt, or as a pleasure and go to the newsletter.I get the newsletter. I feel warriors.com. I'm going to start adding some more, uh, kind of featured breakdowns on individual IPOs. Um, my kind of longer-term vision is to have time to make videos, to put on there as well, to break down some of these with a little bit more in-depth analysis of the actual financials, uh, when I'm reading on Twitter, that kind of thing.So, uh, stay tuned, sign up for the newsletter. Follow me on Twitter. Thanks guys. Have a good week. All right, let's keep it going here. Our next guest has been waiting patiently backstage dog Drysdale. I've mentioned him at the top of the show. He was the CEO of Sayven ticker. CYB N a B. It's bringing him on the show.How are we doing Doug? Happy Monday. Thank you for taking time out of your day to join us here on Benzinga live. How are you doing today? I'm doing great. Thanks gentlemen. Thanks for having me today. You're welcome. So real quick, before we get started for some of our audience that may not be familiar, do you mind just giving us a quick rundown of what it is that Simon does and what the mission is there?Yeah. So Simon is a biopharmaceutical company and we're working to transform psychedelic drugs that we've known about for decades now into actual therapeutics for mental health disorders, like depression, addiction, and anxiety disorders. Got it. So last week, I know we saw some news about M C Y B 0 0 3.So that's one of your guys's PR proprietary drugs. Do you mind just overviewing that news real quick? Yeah. Last week was actually an historic week, uh, in the many decades that people have been working on trying to transform these molecules into actual therapeutics. Two pieces of data came available. One was from one of our peers that for the first time in a 200 plus patients study unequivocally proving that siliciden, which is the active ingredient that comes originally from magic mushrooms, proving that it works in depression and they're paid in helping treat people, people with depression, both the solid and robust resolve at the same time.Simon released data showing that finally after decades, we're able to completely transform this molecule and turn it into something that's actually useless as a therapeutic. The downside visceral assignment historically has been that clinic times are eight hours. So your patients are in the clinic for eight hours a day.And significant side effects and adverse events and would see why B3 we've shown that we can cut this clinic time in half and we can reduce potential for side effects like nausea and headache and other adverse events in half as well. So a major breakthrough. So essentially you're saying that so psilocybin on its own, which, which, like you mentioned, is, um, what's found in magic mushrooms has been proven to help with depression, but there've been downsides, um, to just take an oral.So psilocybin, so with CYB three, you were able to kind of address some of those downsides, um, to, to the actual psilocybin. Exactly. So we've taken psilocybin, we've made it synthetically in the lab and then we've modified it to improve the profile so that it's has a safer profile for patients and pay spend half the time in the clinic.Got it. So, so for some people out there that may have, um, some of these psychological disorder, major depression disorder, um, bipolar, and I know some of them have, have tried a lot of different things and, um, you know, different medicines on the market don't work. So, so is this something that, uh, can be seen as an alternative to helping these patients when those other medicines don't seem effective?Yeah. And once approved they have. So when you look historically back at how we treat depression, we typically use drugs called SSRS, which unlike Prozac. And when you look back over the last couple of decades, on average, a SSRI is typically I know better than placebo in patients with mild to moderate depression and many patients try two or three or more of those Sri's before running out of options.And so a CYB three now provides once it's approved another option for patients to tackle their depression and addiction and anxiety disorder. Did Doug, this has Spencer here. I want to ask you, um, about the, the headline we got late last week, and we're getting again here today about just through the Republican, a bill to legalize cannabis.Uh, I sort of grew up these two things together. I know they're not really technically the same thing, but I sort of look at, um, psychedelics as, as sort of following the cannabis lead in every respect in terms of just regulation and capital markets. Um, I'm wondering if, if, if the move by, by the GOP, if that has sort of changed your, um, changed the, the, the equation at all for a psychedelic regulation at large in the U S.No, not really quite different. So I see that there's a general sentiment change towards looking at these alternative types of treatments and that's all positive. We're looking at drug development that needs to go through the FDA and we're planning studies plan that are coming up in early, early next year.Um, FDA has granted breakthrough therapy status to sub assignment. So they've indicated that this molecule was really potentially important in mental health and da just, uh, came out and said that manufacturers should be making more of these substances to allow more research to be done. So I think we're seeing very positive signs, but DEA and FDA, when it comes to turning these molecules into actual therapeutics that can be prescribed by a physician.So, so Doug is there, uh, you know, a lot of opposition from, I guess, you know, what you could call like big pharma, some of the producers of these SSRS that see, uh, this field as maybe something that's emerging as a competitor to them. So are there, are they, do you see that opposition for big pharma? No. I think the big pharma will see this as an opportunity.When you look across the big pharma space, many of their psychic psychiatry departments have gone over the years. They've become neurology departments. And so there's really been very little innovation in psychiatry in maybe 30 years. So when you look at the total addressable market of all these indications that psychedelic companies are working towards, it's around $300 billion annually.So I think the big pharma will absolutely be interested in this is a space where there's been very little innovation for separately. So Doug for Simon. I mean, I, you know, the namesake comes from psilocybin and mushrooms, but I understand that you're working on other drugs as well. Which other, uh, you know, drugs are you working with outside of psilocybin?Yes. We're working on some other molecules that are related. Uh, these molecules are called tryptamines, which are all like serotonin, which is a naturally occurring. You're a transmitter in your brain. As we're working on some other tryptamines for anxiety disorders. We're also working on a range of molecules called phenethyl means.And these are molecules that are related to MGMA or masculine that might help with PTSD in the future. So we have about 50 molecules in our library currently, and we're taking our lead two candidates into the clinic very shortly. Wow. So, so for investors, you know, our, our, our audience here is mostly retail investors some day traders.What could they be looking out for just in the end, not with cyber in particularly, but just in the industry as a whole, like, are we so early stage that maybe, um, you know, we continue to see some of these names get beaten down or do you think it'll be pretty quickly once we start seeing, okay. People are really noticing that, Hey, look in the psychedelic space, this has actual value and potential, and we can see those investors start coming.Yeah, there has been a bit of a rush over the last couple of years, companies rushing into this space. Uh, but I think we're moving from a period of news to a period of Qaeda. So Simon was one of the first companies sort of the state of this last week. And I think those data points will start to really separate companies from each other and differentiate them.So look out for data. That's coming out of clinical studies over the next six to 12 months, and that'll reset some of these companies apart, I think from some earliest stage organizations that are not quite up to speed yet. Good question here from our chat. Um, how does the FDA's new designation for, for a Simon's work, uh, affect the timeline for commercialization?This is from solar up. Yeah, potentially the breakthrough therapy status, uh, could accelerate the timeline to, to commercialization. There's two things really, uh, the first is that, uh, FDA provides a rolling review. And that just means that they're looking at the data that you submit in real time, not, not in lumps at certain time points, and that's much more efficient.You also get to collaborate with that day and ask questions, which means that instead of guessing what they're looking for, you can take advice on what they're looking for. And typically we breakthrough therapy status to FDA requires perhaps just one phase three study, which are the big expensive studies rather than two.So that can save time and cost of coming to market as well. Got it. So do you have any like ballpark timeline on when you hope to get some of these drugs through the pipeline that the approval? Yeah, so unfortunately drug development is quite slow. Um, but for a reason, the good regaining payments have to be, have to be safe and they have to be tested well so that they can be prescribed for patients.So from where we are today, we're looking at those kind of four to five-year timeframe, still to get through those major critical studies with the first one kicking off in early 20, 22. And then from Brando, likewise, with cannabis or as well as what happened to cannabis, do you foresee it being a case of we get a medical first and recreation and then, and then later on some states doing both at the same time, or, yeah, I don't think so.These are very much going down the pharmaceutical route. And the concept here is that they will be given under supervision or clinical setting and combined with psychotherapy. So patients will go through a period of therapy associated with the treatment, and it seems to be the combination of psychotherapy and the molecule of the drug itself that lead to these good outcomes.Uh, in some studies we've seen that four times, the effect size of SSRI is a four times greater effective at treating depression when combining the psychotherapy, uh, with the molecule. So it's hard to see with this current generation of molecules, uh, that there'll be a recreational. Okay, that makes sense.So, Doug, have you seen a big shift over the last couple of years, just in sentiment regarding, uh, some of these drugs becoming, you know, uh, like viable treatments, because I'm sure, you know, five years ago there would be doctors that scoffed and said, oh, this isn't real medicine, et cetera, but now it seems like more and more people are taking this field seriously.And it's not just doctors. I mean, first of all, psychiatrists are typically fairly open-minded about trying new treatments for their patients, but then you add in the FDA and the DEA throwing their support behind this work. And then also major chip biotech funds. Many of which have invested in Simon are really getting behind this as well.And when you start to see the smart money getting into the space and we know that there's real potential. Got it. So I think one of the, you mentioned that in the last 30 years there hasn't been that much, uh, you know, development or improvement in psychiatric care. Um, and I think one of the problems is that a lot of doctors, you know, see it as, okay, I'm going to prescribe someone, uh, you know, this SSRI and that should help alleviate the symptoms or help solve the problem.But, um, you know, oftentimes a lot of psychiatrists talk about some more holistic measures on top of the medicine. Uh you know, looking at some of these other holistic, you know, things people can do to improve their mental health outside of the drug, or is it simply, um, you're just trying to develop this molecule that you think will be a better.Well, it sounds for the molecule. Let's make sure that these molecules are, have realistic duration that can be scalable and let's make sure they're safe and well tolerated. So we minimize the side effects, but you also want to make sure given the nature of these molecules that they're given in a safe environment.So we've created a psychotherapy program called embark. It takes in six domains of best practice, like a therapy. And we using that to train therapists that will apply to therapy in our clinical trials. And we're making that open source. So therapists can get trained. They want to do that, but also to make sure that we're applying it's like therapy in a consistent way and putting patients in a safe environment.Yeah. I was just curious if that was part of the, I guess quote unquote treatment plan is like, okay, we'll, we'll get, um, this patient on say C Y C Y B3, but that patient should also be getting, I don't know, X amount of hours of sleep a week or exercise, you know, having the other things that help factor into someone's mental health outside of just what drugs they're taking.Yeah, of course. I mean, exercise, eating well, getting good sleep are all good contributors to mental health. When we look back at some of the academic studies that have been performed using psychedelic drugs, uh, those that have reduced or eliminated the psychotherapy have been shown to be less effective.So really does seem to be a combination of the psychotherapy and the drug together. So it forms a kind of a package that helps people overcome the trauma. That's underlying that depression, all. So Doug, what drew you to this industry? I mean, do you have more of a psychiatric background or more of a chemistry background?You know, how did you get here? Yeah, I started out my career in a lab, uh, but I've been in, in, uh, pharmaceuticals in the healthcare industry for 30 years. So I've been developing drugs for, for that time. And, uh, you know, like most of us, you guys too, I'm sure we all know someone in a loved one, family, friends has been affected by depression or addiction.It's tragic as soon as it's all around us. So in 30 years of drug development, I don't think I've had an opportunity in that time to help as many people in such a profound way as we can with the psychedelics. So, so our mission to really turn these into therapeutics once and for all. So, but do you have anything that drew you particularly to psychedelics or was it just that you identified that, Hey, this is a good opportunity here to maybe help tackle some of these problems once and for all the truly groundbreaking.I mean, I can set, I have family and friends have been deeply impacted by this and to be able to combine your work with helping the people that you love is never a bad thing. And it's red, you see data like we see with psychedelics and how profound the effect can be. Literally patients who have spent years of addiction walking away from a psychedelic session and free from those addictive cravings for weeks or months at a time from just one session.I not seen anything like that in my career. So this is an enormous. Got it. Well, Doug, thank you for coming on the show today, we will have to get you back on as Sabin announces more data and news. Um, I know a lot of us here at Benzinga are kind of, you know, following this industry closely and very fascinated by the, um, you know, the progress that has been made so far.Uh, so Doug, thank you again for coming on. Thanks for having me guys. Um, all right. It's one. O'clock we're going to have our next guest on, in his second before I bring them on, though. Uh, AB did you see what Luminari is doing today? L a Z R L a Z R. We had them on the show on Friday and we're up 11% today.Let's go. I'm not saying Benzinga is why Luminari is up 11% today, but I'm also not saying ending is not why. Yeah. I've heard some kids on the street are calling the Benzinga bump. Um, oh, I thought that's something different.I got both errands to live for that one. Oh man. All right. Well, I, I don't even know how to follow that up, so I'm just gonna bring my man Jake on the stream. Jake, how we doing? Hey, how are ya? Thanks for asking what's up. Jake? Who Jasick from trend spider. Jake. I thought of you this morning because we're talking about Grogan and I know that's one of your favorites.So I'm sure you're happy today. I do like it. Yeah. Now I have it as a long-term investment. It's not something I actively trade, so I just keep dollar cost averaging in, but yeah, definitely a nice day kind of a weird market out there. Honestly, got a lot of, uh, what I like to call Christmas colors in the watchlist.You don't really have, you know, a lot of green, a lot of red, it's just kind of just every other stock I have in the watch list is either red or green. So getting the Christmas color vibe there right now, but definitely kind of weird with, with spy is a weekly candle from last week. That's something that does have me a little cautious.I do kind of lighten, lighten some of my positions today. It was a definitely a huge week for me last week in the trading arena. So I definitely don't want to be giving back profits. So, um, I did lighten things up. I still, I think marijuana is probably just getting started, but you know, uh, we have to kind of look at the broad markets before we look at individual names too much.And, and yeah, so with, with spy, I'd really want to, to get above last, week's hide for this to be a little bit of a more risk on sentiment, but Bitcoin is, well, you have this weird pump last night, and now all of a sudden you're back to where we started. So just kind of a weird market. It is OPEX this week.So that's something to keep in mind. Uh, Yeah. So that's, yeah, I'm not in any options positions this week, uh, for that reason, just you, you have some crazy mo

“I don't think there's anything more meaningful than trying to mitigate climate change.” Kate Gaertner is a Corporate Sustainability Consultant who works with name brands, like Nike and L'Oréal, to help reduce the impact their business practices and products create on the planet. Tangentially, Kate is helping to make the processes and manufacturing systems businesses use today more green. From her start in building a sustainable women's athletic-clothing company in Brooklyn to living abroad in the Netherlands, Kate sparked with inspiration to pursue a career that would help her change entire systems in global manufacturing through her company TripleWin Advisory. EU Extended Producer Responsibility (EPR) Laws Tier Emissions Standards Just for listeners of Trash Talking, use code TrashTalking50 for a 50% discount on a digital version of Kate's DIY Sustainability Box Set with purchase of her book "Planting a Seed." Books and box sets must be purchased directly through Kate's website. This week, we're running a giveaway on our Instagram account to win a physical copy of the DIY Sustainable Box Set so head over to our Instagram to win. -- If the content we make on the Eco-Warriors Podcast makes an impact on you, become a sponsor! Visit anchor.fm/trashtalking and click on the link to "Support This Podcast." For as little as $2.99, the cost of a cup of coffee, you can help support the stories we share and help spur more eco-warriors into action. Join the conversation on Facebook and follow us on Instagram. Support us by subscribing, reviewing, and sharing this podcast with others. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/ecowarriorspodcast/support

Episode Summary:On the Benzinga Power Hour, Spencer Israel and Aaron Bry are breaking down stocks making big up moves and down moves. Stocks Talked About In The Show:VMEO, PLUG, BB, SNBR, JAGX, HSDTGuests:Dane C. Andreef, President & CEO Helius Medical (NASDAQ: HSDT) 14:00Lisa Conte, Jaguar Health (NASDAQ: JAGX) 28:00Trung Pham, CEO, RYSE 45:00https://www.helloryse.com/BENZINGA CANNABIS CAPITAL CONFERENCEThe premier gathering of cannabis entrepreneurs and investors in North America returns for a 2-Day Hybrid Event on October 14-15.Speakers will include $SNDL and other major Cannabis Companies, register HEREHosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaarn BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcript Hey everybody. How are we doing? Welcome to whatever this is. Let me Spencer that there's Aaron. And, uh, maybe you should we get the power hour started. It's hump day. Happy Wednesday, everybody.CEO. Jason Razak here with us. The man, the myth, the legend Skeeter shifts on the power hour with us live today. Interesting different innovative companies. You are alive. Power hour, Jessica.Oh, yeah. How are we doing everybody? Welcome to the power hour. We got a lot going on today. We got three guests on the dock. First up. We'll have Dan Andrey from Helios medical on and around 15 minutes or so Lisa county from January Hoff at 1230 trunk fan, the CEO of arise. This is an interesting company.They're not public, uh, but you can still invest in them. I'll tell you all about that at 1245, but I, I heard a, B made some trades. We can talk about those trades in a second. Uh, before we do that though, let's do a quick crypto update. If we can, we'll bring the heat map up on the screen. AB uh, I like white, whiter shades, right of red.I don't like darker. Of of, uh, of right. I like the wider shades of red. It's better than, uh, better than being full red. So Bitcoin's slightly in the red today down half a percent or so if you're in kind of the same story, um, Binance coin, it seems like I don't have to claim climate is having a good week here.Let's let's let's let's give it, let's see if I can bring up, um, here on coin market cap, Binance coin in the last week is, uh, well last week, cause I'm only Bitcoin more than eith um, mark up a lot more than most of the largest crypto. So I'm go Binance coin. Hey, abs and trivia for you. Alright. Ready? Some from crypto trivia for you, what percentage do you think of all the Bitcoin mined in the world?Uh, it was mine in the U S in July, um, 18%, 18, no higher 29. 54. No, not quite that high 35.4%. And this is according to the university of Cambridge. They have a crypt, uh, a Bitcoin electricity consumption index. As you can see there on the map, China, big fat block, a gray because it's zero because it's illegal.Get it. Got it. Good. Good. But anyway, uh, as a result of that, a U S uh, share of Bitcoin mining has increased dramatically. So we've got that going for us, which is nice. As a reminder, you don't have to mine Bitcoin to get Bitcoin. In fact, you can get Bitcoin for free $50 worth. All you got to do is download the Voyager app funded with a hundred dollars.Uh, use the offer code zing, make your first trade and upon doing all of that, you will get $50 in Bitcoin for. On the Voyager app. It'd be when's the last time you made any, uh, crypto related trades? For me, it's been when I bought salon like a month or two ago. Um, I actually sold some of my crypto, uh, probably about two, three weeks ago.Maybe it wasn't really out of any, um, you know, I, I want to sell this or anything. It was more like I have this money in this account and I kind of need some cash right now. So yeah, I sold some, uh, sold some card dominoes, sold some Ethereum, but right now a theory I'm is actually my only crypto, uh, holding.I see tokes and trades in the chat talking about sheep Sheba and every day was she, I don't know she was up again today. It's all I know. Yeah. Spencer, let me go ahead and pull up my screen. I'll talk about a couple of the trades that I made today. Um, you know, so I know we talked about that. I should, I shouldn't be buying options.I should be selling them, but I did buy some more options, but luckily, today they are working out. This is kind of my Yolo Yolo trade account. Not that big as you can see only about two grand in this Robin hood account, but, um, the portfolio is up 17% today. Spencer actually 1738, shout out Fetty WAP. Um, and now it's 1767.So this morning I put these, uh, I bought these $170 calls on Baba that expire next Friday, October 22nd, man. Um, and Baba. So I bought them like probably right around here, nine, 9:40 AM. And now, uh, Baba has been ripping all day. So the, the concept, what was the thought process behind the. Well, so, um, Baba, Alibaba has been, the stock has been showing, you know, relative strength against the market over the past.Um, you know, weaker, if you look at the past week, it's up 10%. Right? I know that. And I'm asking them why today. Uh, that's a good question, Spencer. So why today we saw yesterday kind of actually, uh, it wasn't a great day for, for Baba stock. So w when I S when I look at a long-term chart for this, which on, on Robin hood here, you can't really, you know, not, not the best for looking at charts.I see this continue to go higher to, you know, there's like $190 level, but Spencer, as we know everything, can't go straight up. So basically on any kind of like dips or, or days where the stock underperforms, I'm going to be looking to making trades like this, because my, my thesis is that it will, um, you know, then subsequently outperform the market, the following.So I'm probably going to bomb out of this one here this afternoon. I mean, the contracts are already up about 33%. I'm out this afternoon. Yeah. I mean, there's no reason to hold on to it this afternoon.Well, that's, I'm up 33% on this trade. Um, the, uh, the other contract I, I bought yesterday afternoon was a roadblocks call, um, and kind of something, you know, similar yesterday was a pretty strong day for roadblocks. Um, and it was showing some relative strength against the market. Um, from a technical standpoint, it looked like we definitely were going to go into, come up at least to this $75 level.Um, but as you know, Spencer, I'm not a pure technical or a pure fundamental trader. I kinda, um, you know, just do a hybrid of everything. And so if something aligns, if the technicals look good to me and I liked the company, like I do roadblocks, um, and it shows showing me a good entry point that I don't mind getting in on some of those option contracts.So, um, these ones are actually up. Uh, more than a hundred percent from when I bought them yesterday. So nice little return on those roadblocks calls. Well, I did. I'm glad you said that because I did sell, so you can see yesterday I bought five contracts for $245 today. I sold three of them for 2 34. So I basically got my money back minus, you know, $11 and I'm letting these other two contracts kind of run for, you know, maybe a day or two longer just to see what they do.Nice. Nice job, man. I mean, you, you made two profitable trades in the last couple of days. Take the money run. Good job. Good on you. Yeah. Thank you. I mean, you know, we've talked, I've a question. How long was it between when the idea first occurred to you and when you actually made, made the trade? Not very long at all.I know, but are we talking like 10 minutes or are we talking like. I mean, I have all these stocks that are like constantly on my watch list. Alibaba and roadblocks are definitely on there. And if I, if I, you know, see one that's like underperforming or outperforming the market and the technicals look like, oh, this is a good entry point.I could make that trade in less than, than two minutes. You know, it's as simple as, as picking an expiration date and a strike price. Got it. I got it. I see. I always like chastise you for buying options, but the truth is I really need it, like need to do. I could probably do well. If I traded around some of my longer term positions with via options, it, they just require you to babysit them a little bit.And I don't have the attention span during the day to do that. Um, so I don't know, but man, good for you to, for, to take the money run there. There was also this Q at, well, I dunno if I so. These were up. I saw his soul. I only bought three contracts, so it's a little harder to like sell some and keep some, um, but let's see, I bought them for $73 and they're $71 right now.So, uh, but I did sell one for 95, so I made profit on that one, but I should've sold all of them, I guess. But yeah, Spencer, I mean, you know, if you have a long-term position that, um, is up 20% in a month or something, maybe you want to buy a couple of puts on that just to, just in case it goes down and you're already holding it.I mean, I'd probably rather sell some calls to, to, to get paid for something, but, um, uh, yeah. Yeah, you're right. You're right. I totally should totally should hae a nice job with you. There's a couple of stocks I want to touch on real fast before we get on in a few minutes here. Oh, let's pull up the chart.This has been thinker pro. Whereas my chart was my chart. There it is. Uh, I guess Vimeo here. I just had it in the newsfeed. They posted their September, some, some monthly metrics from September, uh, this morning. Uh, and I guess they're a revenue growth, uh, of 33% subscriber growth, 14% average revenue per user ARPU eight, uh, 16%.These are all year over year numbers. Um, that's interesting cause this subscriber growth number actually slowed and it looks like so anyway, w th the, the, the stock, which I always forget, Vimeo is public. I always forget Vimeo is public. Anyway. It's had his best day in, in a while. This has been pretty much straight down since it wasn't IPO or direct listing.I want to say it was an IPO, um, and pretty much straight down. And since that happened in June, so, Hey, I would probably sell this. I wouldn't buy it up here. I would sell this rip, but I thought this is notable because it's the best day. I think that the stock maybe has ever had on a, on a percentage basis.So, um, all time low yesterday, and today you're up 13%. Th this is a company that I've used before. I, I don't know, like the long-term thesis for it as a, as a stock. So I, I'm not invested in it or anything like that. Um, but yeah, it's one of those companies. What, like you spend through that? I always forget is public.Yeah. What about sleep number SMER? Do you see this one today? Uh, down 5% and this looks, this chart looks down right. Scary to me. Cause you just fell below whatever floor that was in the $90 area or whatever. And I love the low nineties. You are firmly below that now. Um, and we're going to, it looks like we're going to go green for the year.Uh, ready for the. And this thing. Yeah, we opened, we closed at 2020 and at $80 or a, uh, 80. What does that? 83. Well, we'll call it 80, right? Eighty, eighty one. That's what we were closed last year at we're 86. Right now. This is looking downward. It's scary. This is not an inflation hedge beds. Yeah. Spencer, I don't know if you remember a couple of weeks ago, I was actually getting, uh, I had trouble getting a bed delivered and it was from sleep number.No, I don't remember this. So I had an order out with sleep number to get a bed delivered and, uh, you know, first day comes around. It doesn't end up coming. They, you know, I called them that this was the most annoying part is I didn't know. They didn't call me saying like, oh, we're gonna have to cancel this delivery.It's not going to come today. I had to call them and like inquire, inquiring choir. Then finally they're like, all right. Yeah. It's, uh, we're not gonna be able to deliver the bed today, whatever do they say why they said they were missing apart and then the next part? Yeah, I don't know. And then the next day it wasn't like, it wasn't like just the mattress like they were doing.I guess there's some parts to that. And then, so, so I, you know, express my frustration naturally we schedule a subsequent appointment maybe for the next week, the next week comes and same thing happened is happening again. Well, actually this time I called like kind of preemptively, cause I'm like, Hey, just making sure the bed is going to come today between nine 30 and 1230, like we said, and they were like, oh, actually, like we had a computer error.The bed is not going to come today. So two times in a row, the bed isn't coming to me, mind you, I'm sleeping on an air mattress. Um, the company did offer me. They're like, yeah, if you want to go buy a temporary mattress, we'll, you know, rebate you anything up to $400. So I was going to go out and buy like a $400 mattress from Walmart or something, get them to pay me for it and then return the mattress.But I never got around to doing so. And finally, on the third time they did deliver the bed. But at that time I was like pissed off and I was looking at, puts on sleep number, trying to short it, but the stock is just not very, uh, volatile or liquid. So there weren't a lot of good contract options, but now I'm wishing I did.Cause it sounds like if this was like a month ago and I would've made that trade, I might be looking pretty nice. And how long ago was that? So it was like a month ago. Oh man. All right. So it sounds like they're having some, just like everyone else. Supply chain concerns for beds apparently. Right? Gavin pillow sources and components or, or maybe even just getting, getting deliveries done.Um, Well, all right. I didn't know. I didn't know any of that. I know, I know we've cause cause there were mornings where like I wasn't in the office cause I was my bed's supposed to get delivered and that was one of the many running problems with my apartment. But that was one that isn't really on the apartment more on or on sleep number.All right. Um, Hey, our next guest is here and I want to bring him on, uh, cause he's got a couple of thoughts. He's got a couple of things he likes interesting. Um, I think our next guest also has inflated in addition to his own company. I think he's also got inflation on his mind here based on some of the things he just dropped in our, in our, in our private chats.So let's get Dane age refunds from Helio's medical, bring them on. And right now, Dane, good afternoon. How are we doing today? I'm good. Spencer, how are you? I'm good. You must be thinking about inflation. Cause you said you like gold. You like natural gas. You're like uranium. Well, you know, pretty much everything's going up in price, uh, food energy.But if, if, if you'd like the old school, you know, gold Nat gas, uranium, uh, I'm an old 20 year, 25 year veteran of, of hedge funds. I used to run money, uh, for Julian Robertson and, uh, you know, th these names are just starting to explore. Um, on the Nat gas and uranium side, but the goal, uh, golden silver really have been left back, um, along with helium medical technologies, which I'd love to discuss.Um, since that, of course I want it real fast. It's one to Paul, but I just a random uranium chart. Right. I mean, uranium has been one of the high, uh, uh, highest flyers, uh, this year you can go there and go to the you U U or whatever, but, um, yeah, I mean, just uranium, so, okay. actually the CEO of, uh, UVC, uh, uranium energy.Um, his one child Ashley was on our device. Um, he's got a cerebral palsy child and, uh, uh, he was treated with our, uh, devices. So, uh, okay, so interesting. So tell us about what Helios is working on. Helias. Uh, the technology came out of the university of Wisconsin in the late nineties and into 2000. Um, it is, uh, it treats, uh, basically a very common symptom across CNS central nervous system, uh, diseases like Ms, like stroke, like traumatic brain injury, uh, cerebral palsy.Parkinson's you name it? So basically what we're treating right across that spectrum of indications is balancing gait. So most of, most of these patients, uh, can't look left, can't look right without losing their balance or walking forward or going up and down stairs. They just, th they just have a very low quality of life because of the balance and gait deficit, uh, due to these weather, chronic, uh, diseases like Ms, and, uh, and potentially stroke, uh, but also trauma with a traumatic brain injury.And we are the only company in north America right now with a cleared, uh, therapy or ponds device therapy, which I'll talk to, uh, in traumatic brain injury. There is, uh, by health Canada. So we're treating, uh, we've treated well over 300 patients in traumatic brain injury. Uh, it clinically and commercially in Canada, right.Sure. What exactly is the device? Like what is the device? So this is something, you know, in a, a great case. Uh, it's the ponds, uh, neuromodulation stimulator. So I think Tim cook and Steve jobs, uh, would love this device. Uh, let me open it up real quick. Uh, nice handle. But if you open it up and you have a smart device controller, if you could see that and the mouthpiece, so basically I'm going to take the device, the smart device there, uh, which is our controller and then plug in the mode piece.Um, so basically it plugs in right here and the mode piece goes on top of your tongue. Whoa. So 20 minutes a day, twice a day in combination with physical therapy to, uh, improve your balancing gait. Now, w we're we are cleared by the FDA since March of this year for gait deficit in Ms. Patients. Okay. So there's a million Ms.Patients and growing and, and 41% of them have gait deficit. So it's a massive problem in a very chronic well advertise well-lit disease. So that's going to be our first commercial launch in the us, but in Canada, since, uh, late 2018, we are cleared for, for balance deficit due to mild, to moderate traumatic brain injury.And then last year we got our second, uh, clearance approval by health Canada in Ms. In detail. So, and the big news that came, uh, in August of this year, we got our second breakthrough designation device by the FDA. It was granted imbalanced and gait dysfunction due to stroke. Now, stroke is massive. It's seven times greater than Ms.As is TBI. There's 7 million people living with chronic stroke. Uh, 80% of them have gait deficit of balance and gait deficit, and that's chronic stroke. There's also subacute and acute stroke where there's 800,000 new strokes a year 80% of them go right into rehab. So this is not enhanced rehab. It's a ponds therapy with our device.You said the stroke that was in Canada, that wasn't hen. Uh, no, we just, uh, garnered our second FDA breakthrough designation in all. In stroke. So that was the us. So right now what we need, uh, is a pivotal trial for stroke, which we are starting to develop as we speak so very exciting times for such a small company.Okay. So, uh, you're approved, uh, in the us, uh, for only, I guess, a couple of use cases do just Ms. Right. Um, but you're working on getting approval for CP or yes, we have data in CP. Uh, we're going to have data on Parkinson's, uh, in the near future. We also believe, um, we're going to have, uh, a pivotal trial for our second traumatic brain injury trial for balancing gait deficit as well.So we could be the only. Uh, a company that could be, uh, approved in the, in the U S by the FDA and TBI. Uh, and that would be probably 20, 24. Uh, and, and what situation on just like production, like you have the MTA clearance for one, for one thing and the us, but what, what about we haven't commercialized any candidate in two years, we're in 33 neuro PT clinics.Uh, we use key tronics up in Minnesota, publicly traded company as our OEM to manufacturer our controller and our mouthpiece. So, so basically w what transpires here, when we stimulate the tongue, uh, Spencer, uh, in combination physical therapy, we have 143 gold-plated electrodes on this mouthpiece, and it's twice a day for 20 minutes in combination with physical therapy.So basically we are gently stimulating the tongue. It feels like Champaign pop. Or do you remember pop rocks? I don't know if you're that young, the candy. So that's how, that's what it feels like on your tongue. So even when you take your index finger and just touch it, you are stimulating your brain that goes right through your, your, your, your there's 10.And so what's the, the idea is that what it just like improves balance. So basically, uh, you know, if you, if you just sit on the couch with our device, yeah. I have this in your mouse. You're not going to improve your balance and gait. It doesn't work that way. It's in combination. It's like learning to ride a bike again.So you have, you don't have a hundred percent of your balance and gait deficit like you and I have right now, when you have one of these chronic diseases, you have this common symptom in Ms. Or bounce stuffs and then TBI balance deficit in stroke. Same thing, you know, you can't get up without falling. You can't go up and down stairs.You can't look left or turn right without losing your balance. So this is a big deal and it really affects the quality of life for most of these patients. Of course, a lot of them can't go back to work if they've had a TBI. So you, um, it's always interesting. Whenever I talk to someone who like had a career in, in, in one field and left it for another, cause you, like you said, you may have money, you're a professional money manager and then you left to become the present CEO.Yeah. So, so, so Y so, so yeah, basically I, when I, uh, uh, the, uh, maybe partners wound down became a family office, we started doing more private and public. Really in healthcare. Um, and I, uh, I started investing in Helios a few years ago, joined the board. Hopefully I can help management, uh, steer their way through some of the financial issues, compensation issues, and so forth.And just using my background, uh, of, of really being with management teams for the last 30 plus years. So when this opportunity existed, when Helias basically needed a new direction, uh, from, from, from the senior level, um, I volunteer and in August of last year, I started as the interim CEO, I did something special.Um, I took no compensation whatsoever for about 11 months, no salary, no stock option, no cash. And then basically, you know, from then on, I start building up the new team, I helped bridge the company financially in two deals. I've been investing in every deal, uh, you know, myself and my family owned well over 9% of this company right now.Um, we just brought in a new CFO, Jeff Matthiessen from the board, um, as well as our new chief medical officer, um, who who's a KOL Ms. Expert neurologist as well. And then the head of sales and marketing came from leaving Nova, which is the biggest neuromodulation company, uh, in north America right now. So of course from our chat, uh, before we wrap up here is the treatment.I presume it's a temporary improvement. You have to keep using it. Right. So right now it's a 14 week treatment, uh, twice a day for 20 minutes. Uh, in combination with physical therapy, your first two weeks are in the neuro PT setting. The last 12 weeks. Um, you do your exercises at home and you come in once a week and you, we download your, uh, data with your PT and we look at your progress and improvement.So, so right now our data, you know, is, is, is really for short term only, but we're looking to get a longer-term data as well. We have it. In traumatic brain injury, we did a wash out. Uh, it, it was excellent data and that garnered our, our first clearance by health, Canada and TBI. And then I guess, like what, what are the, um, uh, the best you can provide, like a timeline on, on, on when you'll get the FDA clearance for anything, everything you want to get clearance for.Yeah. So it's all about expanding the label of this platform technology. So first and foremost is Ms. In the U S we're looking to do a pivotal trial and stroke. Uh, we're looking at probably, you know, first half, first quarter, 2024 for FDA clearance in stroke. So, you know, and we're hopefully also get a parallel pathway TBI as well.So to do all this for the next two years, Is is a massive lift, but it's a, it's a fantastic lift. The testimonies that we have coming from our clinicians, from our patients in Canada, the, the, the technology, the therapy, the ponds therapy works. It truly works. And it changes people's lives. Their quality of life improve.Uh, their there's so many positive side effects to this therapy. Um, I just can't make claims, uh, you know, but we just hear a great story. I, I wouldn't want you to make claims anyway, they couldn't be backed up. And Andrew, if he's the CEO of Helios medical, ticker chart up on the screen game. Thanks a lot for coming on today.Thanks, Spencer. Alright. Bye-bye Hey, AB where'd you go? My man, come back to me. I'm right here, Spencer. You were just killing it on the interview. So I did not want to, I know, I know what happened. You stepped away to go to the bathroom. Yeah. Yeah. That's. I got you. Anyway. Um, well, yeah, Spencer. So as you mentioned, we got a pack show today for three guests.That was our first one, Dane and drift and drift. Um, we've got another exciting biotech company coming up as well. Spencer, Lisa county, and I see her here backstage from Jaguar health Jaguar. She bring Lisa on. Let's do it. Spencer. I've always wanted, I love seeing Jaguar Jaguar with a British accent. I bet you that's how it's pronounced.We can ask, we can ask her. Maybe we should, let's get these on. You want me to do it? Oh, there she is. Okay. Well you say good afternoon. Good afternoon. I just heard the end of that conversation and it sounded very similar to ours label expansion for an initial indication, not making claims outside your initial indication.Right? Right. So tell us about what you're working on and what your initial indications are. And then we'll, we'll go from. So while we're working and we do all plant based drug discovery, some plants that are used traditionally from the brain forest. And we did take our first product from a tree growing in the rain forest to a first-in-class FDA approved drug called my Tessie.And it's a drug for gastrointestinal symptoms. It normalizes gut function. And it's initially approved in people living with HIV aids and has multiple follow on indications. One of which is in phase three clinical trials right now for cancer therapy related diarrhea, which is the biggest side effect associated with cancer therapy and affects everything from dignity and quality of life.All the way to outcome of the patient's cancer therapy, because the interruption with the gastrointestinal distress causes patients to take drug holidays or reduce their dose, or even change their life saving therapy. And then there's multiple other follow on indications, IDs, IDD. We have a rare disease and short bowel syndrome.So it's a real pipeline within a product. Where w what is the market size here? We're talking to anybody with any sort of gastrointestinal problem. Eventually as we get to all the different indications. So right now our label, for example, is only in people living with HIV aids, it's a chronic label, chronic administration.Um, and then we're going for cancer. We'll need to do an additional clinical trial for Uribel bowel syndrome and additional clinical trial for Crohn's disease, inflammatory bowel disease. So one by one, we'll be able to get to all the patients in need around the world. How long do those trials take? Well, it depends.Um, so the cancer trial is where about, um, nine months into it and it will be completed about one year from now. It's about 250 patients. It's very interesting. Literally my Tessy. So it's the product in the same dose, the same formulation that we have in commercial use right now for HIV. So when we think about risk management, most new drug applications fail because of a safety issue or a manufacturing issue.We obviously already have the supply chain worked out and we have a chronic indication. So for example, we have two year carcinogenicity. So it's a matter of conducting that pivotal trial and risk reduction for us. It's spending a lot of time with the FDA to make sure we have discussion and agreement on that pivotal trial design on enrollment criteria, endpoint definition, which will define where you're going to be able to make your claims and promote.So you don't finish the trial, have a successful trial. And the FDA says great. You know, if only you looked at one additional thing. So anyway, the bottom line is each additional indication is probably about a two year. So, well, in this case, we're looking at like the next catalyst for Jaguar health being like a year out from now.Well, not the next catalyst. That's the, that is a very big, important catalyst because you asked about the size. So there's diarrhea is the number one side effect. We cancer therapy and there's nothing that's been tested and approved specifically in that indication. So what do we know about, of supportive care in Canada?Um, chemotherapy induced, nausea and vomiting. And that is a market that is expected to be the third party analysts about a $3 billion next year. And you typically take those agents for like the first three days of the chemo cycle, whereas diarrhea with targeted therapies, these therapies that patients stay on chronically to stay in remission for years at a time is occurring, you know, every single day.So that's a huge indication in terms of the number of patients, the impact we can have on their life. And of course the revenue that results from that, but near term catalysts. Yeah, we have the brand name is my Tessie. The generic name is and is getting ready to be launched in December of this year. As under the trade name can Aaliyah for chemotherapy induced diarrhea in dogs under a conditional approval from the FDA, because it's, it's called mums, which is like an orphan designation to get products available to animals in need.And in this case, dogs in need and dogs are remarkably predictive of the human situation. The way our product works in the gut is highly conserved in the physiology of the dog. Gut and dogs typically get many, um, human designated cancer agents. So we're very excited and, and that's, you know, a relatively small market compared to the human market, but a very important market.And it's a very near term, um, event for the. And so Lisa, you mentioned that, um, you know, diarrhea and kind of, you know, some stomach problems are one of the main, um, side effects of cancer treatment. Um, so, so with this medication also help with weight loss. I mean, I assume the two are associated, uh, wait, not with a receipt, what it does, this is not a claim.Uh, but when patients are. You know, getting dehydrated because that's the thing of diarrhea, like cholera, for example, what kills you, not the Colorado infection. It's the dehydration that occurs from that. Ultimately organ shutdown, et cetera. So when you're not dehydrating, you're maintaining your weight.And we have had patients just say to us, you know, this is lovely. I don't, you know, I don't have a sunken face anymore. I'm able to maintain a healthy body presence. That's not a claim that we have, but you know, you could just imagine from preventing the dehydration, right? So, so by preventing the, uh, you know, diarrhea and those effects, you'd be, um, you know, retaining more of that hydration that.And, you know, another, another indication that we're pursuing, which is going to get to what you're thinking about short bowel syndrome and the intestinal failure associated with that. So this is another near term, uh, um, event in the company. So short bowel syndrome, we have about an intestine that's maybe 20, 25 feet.So short bowel you'll have less than five feet, maybe as little as 30 centimeters, it could be congenital. It could be due to cancer necrosis. It could be due to an accident, but normally what's going on in your gut. You have the secretions coming in and then you have the absorption of the nutrients. Your proteins, your carbs, your fats, your vitamins, your minerals.And if you have a short vowel, you don't have enough time for those to be absorbed appropriately. So that's an indication that we're pursuing initially in Europe, because we have orphan drug designation here in the United States. We have filed for orphan drug designation in Europe, and that has been accepted the application with orphan drug designation.In Europe. We have the possibility for an accelerated conditional approval. You can get it into those patients sooner. And the thought is that you're giving them more time by normalizing the secretions, which is the mechanism of action of or giving them more time to absorb the nutrients of life and reduce the morbidity.And also, unfortunately, the mortality associated with that indication and that is being funded. With our European subsidiary Napoli, you merging with a spec in Italy called the dragon spec, and it's all filed right now with the Italian government and should be consummated in less than the next month. No, that's no, that's interesting.All right. So we got SPACs we got Italy. Uh, why, why, why go that route? So again, we wanted to be in Europe, right? And, um, for what I told you about the conditional accelerated approval opportunity for an orphan designation. So we licensed the parent company, Jaguar or Jaguar. However you want to say it, uh, did an exclusive license for the European rights to all the indications of profile Ameren.It's a typical license agreements. So there's benefit to the parent company of an upfront payment milestone payments, Royal. And that clinical data that will be generated in Europe is available for the parent organization to utilize in the United States. We try as best as possible to pair our clinical programs with, um, non-dilutive financing.So one way to achieve non-dilutive financing in this situation was for the subsidiary Napa. We used to be funded by a third party, and there happened to be a dragon SPAC in Italy. Why Italy? Because Italy is the only country where a spec can name their target company. Well, they're raising their money as opposed to the way it's typically done.Yeah. Italy is the place where that happens. Did you know that? I did not. I mean, we probably should know that Spencer considering, you know, we're in this field, but maybe, maybe Chris and Mitch are our resident spec. Experts knew that, but, um, I did know. Well, I think that would be a game changer. Imagine if that was the case in the U S if you can name while you're raising your money from your pipe investors, you can say, Hey guys, you should come to because a year from now we're going to go buy this company.Or we think, oh yeah, happy, happy Muhammad in the chest saying investors to low. Never mentioned that maybe next time he comes on the show. He'll, he'll, he'll talk about that spec process. Um, but I mean, I feel like a lot of times here with the specs where they're not allowed to disclose it, like oftentimes it's rumor and I, I sometimes it's kind of like one of those, uh, you know, trial balloons situations where I think they like purposely let it leak and see how the responses, but who knows.Wow. Yeah. At least you just taught us all. I saw new today, blue my house. Yay. Do it my best. Yes. Years ago, I don't know. Let's say 5, 6, 7 years ago. Italy was the second most active market in specs for that very reason. Um, it cooled off for a bit when maybe some of the spec sponsors were little too generous with their return to themselves.Um, but far spec spots. You're kidding. Right. Oh man. Do you have an, another connection to Italy outside of that? Lisa, we do have another connection that we have very interesting looking at the plants behind you, Spencer, the largest plant like tree based GMP manufacturer in the world is in Milano, Italy called in Dana.And they are, um, scaling up to be our second or our long-term large-scale, um, plant manufacturer. We've worked with them for over 25 years and in fact, they just did a nice investment in Jaguar, in the parent. Well, I, I will pass her compliments to the chef. I'm not responsible for these decorations here. I I'm stuck at home in, uh, uh, quarantine right now.So I'm sorry, this is what I've got. I got, I got what I got, what I got. So I'll pass her compliments to the chef on that, uh, for the chef or the chief that to, uh, Lisa Conti is the CEO of Jaguar health. Um, joining us today on the, on the para or Elisa. Uh, thank you so much for stopping by. We would love to have you on again.Uh, as we get closer to those, uh, the, those next catalyst. You got it. You got it. Thanks a lot, guys. Have a great rest of your morning, Lisa man, we're doing the specs wrong in the U S I think is I think we need to let these come. Can you even imagine. So essentially let's back this up for some maybe if any of our audience members don't understand the kind of difference.So essentially, and correct me if I'm wrong here in the states, you have a special purpose acquisition company, a quote, unquote Blake blank check company. That's raising money from investors to then go buy to take another company public, right? So you actually, you have two years, so you raise your, you go out and you raise money from investors and then you IPO that company.But your company is not, it's just a blank check. It's a shell company. It doesn't, it doesn't do anything. And you raise money with the idea that within two years from the second we IPO, we have a two year clock. We got to buy, we got to use the money that we raised to buy another company. Um, Otherwise, we have to return that money to all the people that invested in this back in the U S you're not these specs.I'm not allowed to talk about their targets before they have a deal. I apparently, generally, that's not the case. You can raise money with the intention of saying, Hey, we are going to do that. You should buy, you should invest now because we're going to buy X company down the line, which so let's say I'm going to, I'm an Italian spec.Oh, oh, we kind of lost you for a sec, but you're back. So say I'm going to Italian spec called I spec Italian spec, and I'm raising money. I can say we are raising this money in goals of taking Ferrari public or. Well, what'd you say? Or, or, or Benzinga, or Benzinga w we, you know, we can, we can say our target now here, where if you say you look at, um, I can't even think of like, uh, uh, one of the specs, like the, uh, actual spat, like Northern diamond peak holdings there there's diamond peak holds you don't know there are rumors, but you don't know for sure that diamond peak is, you know, targeted and Clover health or whoever it is.Yeah. Um, coupon boy brings up a good point in the chat. Us can say, what sector are they targeting? That's a good point. And they can, so a lot of times people will, uh, you know, infer like, oh, this company's raising money in the healthcare space. They're going to target a Clover or whatever it is. But, um, I, yeah, I know Ferrari is already public.I was just thinking of an Italian company off the top of my head. I w I don't know, maybe another Italian company, um, uh, Oh, wait, I think I was going to say natala, but I think they got bought by a guy who owned with Hela. I think, I think there's mandolins. I forget somebody big owns Metalla anyway, um, IPF discord.See, I feel like there are some where it's like very like clear what the, what the company is. Um, what's the one, the one that's going to take apex public. It's like Northern, uh, something apex clearing bad close yet, or no, no, that didn't close yet. I guess that's let's search and that's the best part of the crows you can search for it.I think it's like fitness V or N T S Northern store on investment. Yeah. Yeah. Apex FinTech. So the only reason that that's like out there in the public is because they, the deal's already been in now. Okay, here we go. Now we got, we got the real spec expert in the check. Chris , the filing was a mobile game deal that happened this way.We w we got a lot of knowledge, a hundreds Kurt community. Uh, I needed to tell I was all my son born. They're owned by forever. Thank you. Which was like a family, family business. Thank you, Andre. Andre must know knows his confectioneries. Uh, thank you, Andre. Thank you, Chris. For dropping. Yeah. Okay. Thank you.Gucci, another Italian company, their name, all the Italian companies. Uh, anyway, Chris catchy today, we learned that SPACs can name the targets ahead of time as the raising money in Italy. And, uh, we thought that was fun. So, um, yeah, I mean that, you know, we all learned something today, so I'm not very often.We do back to that biotechs interviews on the show. Probably not something we'll do a lot of, um, Let me, let me let you in on a little secret though, these biotech companies, um, are very easy to book, right? They love talking about, about themselves. They're very, they're, they're very responsive. That's why you may see some, a lot of biotech companies get, uh, some press because they're very easy to book.So, uh, some inside baseball there, but, but thank you to, uh, to, to Jaguar and, and Helias today. We were supposed to have a third guest. Oh, I see him here. So our third guests, this is interesting AB this, uh, we'll, we'll bring them on in a second. Um, his company is not public, but that does not mean that we invest in it.So Spencer, if, if you know, for some of our audience out there, if you're a big fan of the show, you tune in with us, you know, day in and day out. Um, I had my good friend Julian on the show a week or two ago from, from core connects. And essentially what core connects does as Julian explained was they helped set up private companies that are raising money, either through reggae or reg CF, um, you know, which just allows retail investors to purchase shares of private companies before they go public.Um, and core connect sets up the technology to allow these companies to do so, uh, you know, directly with that company. So instead of having to go to a website, like start engine or something like that, um, you can go straight to the company's website and invest in. And, uh, Trung fam who's coming on right now.He heads up one of these companies. He started his own company called rise. We're going to get to talk to trunk about that. And core connects is, you know, has set up the technology to allow investors like us, like you and I Spencer, to go straight to RISE's website and purchase shares of the company before it goes public.Uh, you know, for hundreds of years, however long people have been investing in retail investors have not had access, uh, to purchase shares of private companies like this. So this is something that's kind of new and exciting. All right, that's good. That's good. Strong on here. Truong. How are we doing this?This beautiful Wednesday. Hey guys. How's it going? Was I, can you correct me? Was I incorrect in everything I said there? No, no. Everything you said was correct for sure. All right. The way there's a first time for everything. Goodness. All. Alright. Trunk, tell us about rise. This is interesting because there, uh, There are some big players that are.Tangentially related to you. So, so tell us what you're working on. So we're in the smart home IOT space. We create a little device, as you can see on the screen there, and I'm holding one up in my hand, and it's essentially a smart home device that you Mount on the window frame, and you're able to motorize and automate your existing window shades.So the problem that we're so solving today is that most window coverings in the market they're manually controlled. And once you install them, you can never automate them again. You'd actually have to replace them with brand new motorized shades. So we came up with a suite of devices that allow you to motorize your existing window shades and blinds.And, um, no, we're a category within the booming smart home market. Um, you know, over the last few years you see a lot of exits by some of the large players like Google buying nest for 3.2 billion and Amazon buy and bring recently for 1.2 billion and so on and so on. So there's a lot of, um, activity in the smart home space.And not only that. Even though we're a smart home device to motorized shades. We do target the much larger and lucrative commercial market. And, um, when we're talking about the commercial market, you know, there's a huge opportunity for energy savings and that's, what's really appealing, appealing to these partners that we're with working with, where they're able to save a substantial amount of energy just by passively opening and closing their shades to, you know, one reduce solar heat gain and reducing cooling, or to, uh, reduce indoor lighting use.And, and that's really, um, that's really our focus as a company. So can, um, can you set this on like a timer automate it? Yes. So you could set a schedule. So if we're having open at 7:00 AM every morning and then close APM gives you that extra privacy, uh, if you're heading out of the house and your window shades, you're opening, you forgot to close them.You can do that remotely through the app. You can connect it with Google home, Amazon Alexa, apple home kit. So the primary smart home players out there. Okay. Marshall side, we create customer API integrate. Okay. So, so trunk, I imagine, you know, there are a lot of commercial real estate companies out there that might have an ESG focus.You know, as you mentioned that, you know, this device from rise can help with energy savings, uh, is that a potential customer, you know, like big commercial, real estate companies that are creating big office buildings that you can say, Hey, you can put one of these in every office in this building and it will help you with energy savings.Yeah, definitely. So, um, we actually received a $4 million Canadian clean tech grant to develop our second gen. Built on the requirements of the commercial partners required. So we're working with a few large commercial players, hotels, office spaces, and whatnot. And, um, you know, they actually had very simple use cases.They wanted, they wanted us to lower the shades during evenings or weekends. Why? Because especially during the weekends, they usually don't have tenants in the office. And what happens is that if the window shades are open, all that sunlight during the summer is coming in and the HVAC system is cooling an empty room.So it's just wasted energy. So just by lowering the shades during these times, they block out that solar heat gain and reduce that inter cooling requirements. And, um, they could save a substantial amount of energy up to 24% in cooling and 74% enlightened use. So, so obviously, you know, Tron, you are targeted.You, you know, this is a smart home, um, appliance, I guess that's the right word here. You have seen what happened. You mentioned already you saw what happened to Google nest or nest. You saw what happened to ring with Amazon. Is that like a logical end point here for you? Uh, definitely. So when we think about the type of company we want to become and where w we'll end up, I think, um, the most ideal exit would be an acquisition by a larger player.Um, I'm not going to say it's going to happen. Um, obviously I can't predict the future there, but, you know, we are positioning ourselves to be an attractive, uh, exit attractive, acquire, an attractive target. Um, and you know, just like reading, they have the, the, um, potential of YPO and I believe we have that potential to, but I think at the end of the day, we are going to be one of those companies that another big player just comes up in a.Well, what can you say about your, your, your sales and revenue right now? So today, uh, we've generated over 4.5 million in sales and that's all audited. Uh, today it's probably closer to 5.5, um, on audited. So how many devices, how many devices that like w w it retails for 1 49? So it's well over well, over 35,000 devices today sold, we just began shipping our second gen and we are launching.Um, so this product works with anything with a B to chain or cord loop. So the traditional window shades and blinds, but we are creating a device for drapes and curtains. Um, a lot of the whole top artists that we're speaking with all have drapes and curtains for, you know, art purposes and whatnot. And, um, that's a retrofit, um, smart drape solution.And, uh, we'll, we'll be doing a formal launch, um, hopefully before the. Okay. Does rice have any, uh, you know, patents on this technology that would kind of prevent, say, you know, a Google home or Amazon to go out and developing their own, the automated blind system? Um, so it's funny. Um, when you speak about Amazon, um, we invented this concept, so we have four fully issue patents and a number of more, uh, patents pending.And, um, you know, when you create a physical product like this, a hardware product, you're going to get copycats coming out of China left right. And center. Um, but because of our patents, um, we actually have an Amazon court judgment victory. And what that allows us to do is that any time a copycat pops up on Amazon, we follow an Amazon.If they kick the seller off. And, um, many times I get these long letters from the seller apologizing and whatnot for infringing on the patents, but our pans are that strong. So, you know, anytime you might see a copycat, they might be there for one or two days, and then they automatically get removed because of our patents per time merged with a solar panel.That's all sorry, probably so proton from our chat says you should merge with a solar company to have your have shades that provide solar power. Um, I've seen other solutions like that. Um, we're not focused on that yet. We're focused more on the IOT connected devices space. Um, yeah, the, the whole idea of solar and generating energy that's that's beyond how long has it taken to bring this product to market?How long has it been developing for? Well, um, our first gen, uh, we began R and D during 2015. It took us about two and a half years before we actually got to market. Uh, that's includes, you know, prototyping going through production for the first run testing, all that kind of stuff. The second gen took a maybe only a year to develop.So we've, we've improved the whole product development life cycle for us. Um, so trunk backing up to what kind of, when you, when you first had this idea and started the company, I I'm sure you had, uh, you know, critics that were saying like, yeah, this is a good idea. You can't make a whole company out of, out of this.What, what, what did they, you know, get wrong or see wrong that you kind of saw differently at the time? Um, well, I have a finance background, so I actually did a whole analysis on the industry. And you have large players like Sofie they're publicly traded $5 billion market cap. They focused on motorized shades.Um, they, the leading player in the marketplace today and they only talk to the 10%, uh, because their solutions, uh, must be purchased with the actual window shade. We're talking to the other 90% of real estate asset classes that already have window shades installed and may not want to replace them, may want a retrofit solution.So you can imagine how big the opportunity is on the retrofit side. Um, and not only that, uh, solutions by Sofie boots on the ground, some of these other larger players, they're $500, a thousand dollars per. Ours is $150 product. So it's a much more affordable price point. The real estate developers and landlords are attractive to it because they think about payback period.They think about, well, I'm not going to install these neutrons because they're going to cost me, you know, a hundred thousand dollars for a hundred windows versus yours, but that might cost, you know, 15,000. So the payback period is much more attractive. Um, they could earn their money back from savings in under three years.Um, so, you know, it's definitely a bigger market and to allude to ring, um, you know, Regan was a great success story. Um, they sold video doorbell systems they're and they were in a highly competitive market. They're in the security camera market, but they dominated the video doorbell. And, um, what was interesting was that ring only sold to single family homes.There were a residential smart home player. They couldn't sell to multifamily. Um, they couldn't sell to commercial. They can't sell to hotels because their security system for residential. We don't distinguish and discriminate between the asset classes we could sell to any asset class, single family homes, multi-family hotels, commercial office in your housing.Is this a, uh, like as far as the distribution is, it's like a direct to consumer thing. Are you in like home Depot or are you going direct to the manufacturers? I mean, so, um, historically to date, we've generated all our sales online, so direct to consumer online. However, next year we do have plans in place to be in retail.So you mentioned home Depot, um, and then, uh, B2B sales is something we're highly pushing forward. So speaking to these large real estate developers and landlords and pushing high volume sales, Trunk. Do you have any idea down the road, kind of what that makeup will be like kind of percentage wise of what percent of the revenue is coming from direct to consumer sales or single a single home families versus, you know, the more commercial real estate like?Yeah. So I'm speaking to our colleagues in the smart home space. Uh, like we talked to all the major players out there, all the big players that every one recognizes and we do know the makeup. Um, online is a very small portion. It's only about 7% of the market for us. So, uh, it leaves a big opportunity for us when we actually enter these other sales channels.Retail is about a third of industry revenues. So the Costco's the best buys the home depots. Uh, but the largest and most lucrative channel is B2B sales. So B2B sales to large real estate developers, landlords commercial office, senior housing, um, you know, those type of players. And, uh, that's eventually where we went to.Got it. Um, well, trunk fam CEO and founder of rise. That's R Y S E. I'm going to go ahead and drop that link in the chat. If anyone wants to go check out the website, see how you can become an early investor, um, trunk. Thank you for coming on the power hour today. Uh, thanks a lot. I appreciate it. And again, the, the offering page is invest dot hollow rise.com.Got it. Yes, man. Dude, the future is now we're going to have smart everything like I'm, I'm AB I'm like you, or I'm not going to be ready to buy a home for awhile probably, but like the home, the home that you and I do buy that first home, whenever that happens 10 years or whatever, like it's going to be insane.Like the amount of stuff. Shit. Well, think about it. I mean, look at one of those, you said it was like 150 bucks. We could go out and buy like a house that was built in the eighties or something, Spencer and configure it out to be a smart home for probably not that much money. And I think that would, that would, uh, you know, raise the value of the, of that home a lot.Um, he mentioned, he mentioned ring quite a bit there. I'm pretty sure it correctly wrong in the chat or correct me if I'm wrong. I think ring was a shark was brought up on shark tank and none of the sharks wanted to invest. Yup. Yup. I want to plug into another show for AXA for a second. If, uh, if you ever, ever listened to NPR, there's a podcast called how I built this and th th they're pretty good.Uh, some episodes better than others. Uh, they're pretty long. They're like over an hour. Um, but they talk to founders about how they built their companies. And the episode with ring with the founder of ring on the show was, and away the best episode of that show ever. It's a podcast. How I built this with the founder of ringers and his name is Jamie something.I don't remember his last name. J J what'd you say? Diamond fast. Kidding. No, uh, here I'll look it up. Ringing founder. It's Jamie, Jamie Siminoff I think is his name. Anyway, that episode was like amazing. If you want to listen to like someone who really like struggled to build this company, we like, like you said, went on shark tank.Didn't get a deal. Like really inspiring stuff. That's trying to be the biggest, uh, like maybe the biggest company period that's been brought on shark tank, but by far the biggest one that was on shark tank and then no one, I don't know, I haven't seen the episode, so I don't know if like they tried to get equity in it and the deal just, you know, it wasn't good enough.Or if they just all said like, and for that reason I'm out and it just missed that it's come a long way. When I was growing up this, the, the smart home devices was clap on clap off that's. That's what I was when I was growing up. And even before that, we've come a long way. You can automate your blinds and, and then some, okay, Hey, it's one o'clock uh, no.Get tactical today because Neil is in New York where you. Tomorrow on Friday for our Benzinga cannabis capital conference, our first in person events since before COVID started. So BZ cannabis.com to learn more about that, Neil will be back on next week, uh, for his show. Uh, we do miss him, uh, dearly, but so w w what we've got right now is a replay of the roadmap from okay.From yesterday. And then at two o'clock, we've got Muhtar bust. I'll be back on at three 15 through 20 is for, at, to close with Joel Al cannon. And, uh, that's what we got hit that like button, please. And thank you. Thanks to everyone on the chat. Thanks everyone for watching. No, no power hour rest of the week, because.As mentioned our cannabis conference that will be streaming as well for the next two days, starting, uh, tonight, actually. Uh, but AB good job. Thank you, Cameron. Thank you. Manny. Shelly, Chris proton. Happy everyone in the chat. Santo. Appreciate you. AB appreciate you go, go. Uh, do whatever it is you do over there and you keep tabs on the office for me while I'm not there over at out ski as David Greene would say, it's true to say that.Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

On Episode 21 -- kicking off Season 3 of Creative Distillation! -- Brad and Jeff speak with Chuck Eesley, Associate Professor at the Stanford University School of Engineering. While enjoying some negronis mixed with Ada Lovelace gin, Chuck shares a brief but fascinating history of Ada, widely considered to be the first computer programmer (from the mid-19th century!). Tangentially, Brad brings up bitters and Jeff's over/underuse of them in this particular(ly strong) cocktail. This segues to an insightful (and fun) conversation about Chuck and Yong Suk Lee's research on the efficacy of university entrepreneurship programs. The results may surprise you. Learn more about Chuck: https://www.linkedin.com/in/eesley/ Read the paper: https://onlinelibrary.wiley.com/doi/full/10.1002/smj.3246 Comments/criticism/suggestions/feedback? We'd love to hear it. Drop us a note at CDpodcast@colorado.edu. Thanks for listening. - An Analog Digital Arts Production for the Deming Center for Entrepreneurship
Produced, recorded and edited by Joel Davis "AcidJazz" by Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0
creativecommons.org/licenses/by/3.0/

Joselyn and Lauren just have a lot going on right now and they are talking about it. Tangentially. Chaotically. It's pretty great, actually.

This guide is 2,748 words, a 10 min 59 sec read time (19:33 minute listen). Subscribe here. 📍Introduction: Whether seeking marriage or simply a romantic encounter, a dater armed with etiquette has a higher chance of success. Etiquette refers to the customs and guidelines that help people act with more sensitivity towards others. Contrary to popular belief, etiquette in dating is not outdated, nor is chivalry dead. Both, however, have evolved in the modern era. From swiping to snuggling, let these tips & tricks inspire you to elevate your game. 📝Notes, Tips & Tricks: General Principles:Dating shares the same word root as data. Approached through this lens, dating is a "data-gathering activity" that allows two people to learn about one another & explore whether or not they are romantically compatible. There's no need for high expectations, build-up, or pressure. You're just getting to know someone. Dating goals can vary widely (e.g., practice for marriage, fun, personal growth). If you have strong preferences (e.g., for something casual, something serious), it’s best to state that pretty soon. Regardless of your ambitions, however, remember that people can be easily hurt. Treat others the way you want to be (or you think they want to be) treated. It takes two to tango. This goes for both positive and negative experiences. If the date (or relationship) goes horribly, it is typically not one person's fault. If it goes well -- same story. It's best to approach & treat people as individuals. Believing that "all women are x" or "all men are y" can lead to false negatives (aka type II errors) and aloof behavior.Asking Out & Being Asked OutWhen asking someone on a date, be specific (e.g., "Would you like to go for coffee this weekend?"). General questions can be hard to answer (e.g., "What are you doing this weekend?") If you're the one asking for the date, give as much detail as possible (e.g., time, place to meet). Waiting until the last minute to pick a spot or time can make it difficult for your date to plan accordingly (e.g., clothing, transportation, scheduling).If you are asking someone out, it is typically assumed that you will pay. However, this can vary by wealth levels and cultures (e.g., in Europe splitting the bill is more common). If you suggest the place, it's nice to at least offer to cover the bill. Choose something less pricey if you are on a budget (see dating budget reference guide below). Relatedly, if you are the one being asked out, don't suggest a more pricey option. It could make your date feel uncomfortable & pressured. When asking someone out, double-check to ensure it aligns with their interests (e.g., don't book rock climbing without confirming your date isn't afraid of heights) If booking a restaurant with someone new, it's polite to ask about dietary restrictions. Relatedly, if you have strict food preferences or allergies, let your date know in advance. Don't cancel a date unless absolutely necessary. Scheduling and rescheduling a date over and over is unromantic, irritating, and can send the message that you aren't interested and/or reliable. Don't cancel on pre-existing plans to accept a date. It's rude to cancel on someone for a better option. Suggest meeting at a different time. Don't give false hope if you have no interest (e.g., I can't because I'm very busy with a work project right now"). Also, don't lie. It can come back to haunt you. Talking/Texting/CommunicatingDaters differ on their willingness to talk, text, or video chat before meeting in person. If you have strong preferences, share them. Be flexible.  Many people these days prefer to have some form of verbal communication (e.g., zoom/facetime, phone call) before meeting in the real world. This is a new norm. Embrace it! It can save you a lot of time and money. Tangentially, too much texting before meeting in real life can lead to a loss of momentum. It can also result in misinterpretations or projections. It is customary but not required to touch base (e.g., text, call) before a date to confirm details. If you are the one planning the date, try to do so the night before if possible. It creates a sense of anticipation and gives your date plenty of time to prepare. Preferences around grammar and punctuation differ. Matching your date's style is the best bet for harmonious text communication. Ghosting (not returning someone's text or call) is very rude & can leave someone hanging on without closure. If you aren't interested, thank your date for the time together and decline their offer. (See Ending Things Nicely below) Honest, direct communication can help avoid a lot of confusion & heartache. Sharing your feelings can go a long way. Nobody is a mind reader, and honestly stating what you are experiencing can go a long way in providing clarity. For inspiration, check out the Feelings Reference Guide below. If your feeling statement has the word "that" or "like" in it, you likely aren't speaking of your feelings (e.g., "I feel that/like you always do X" is a thought, not a feeling).  In the beginning (e.g., first 1-3 dates), it's typical for one person to take the lead in proposing dates and the other to follow by accepting or rejecting. If the lead is interested, they will ask for a second date. If you want to (co)lead, ask for the second date! Texting frequently between dates can hinder the romance associated with anticipation (e.g., "A relationship rarely dies of starvation, yet often dies of indigestion."; "Absence makes the heart grow fonder.”)On the Date: Make every effort to be on time. Nobody likes to be kept waiting. Additionally, tardiness implies you value your time more than your date's. If possible, arrive a few minutes early. Running a few minutes behind? Call (and apologize.)When picking up a date, it's polite to go to their door & ring the doorbell. Don't wait in the street or honk. If driving, tidy the car. If there are crumbs/dirt inside, vacuum. Don't arrive low on gas (or electricity). Holding doors open, allowing your date to exit the elevator first, or helping someone into their chair are chivalrous but not required. If you feel the desire to try these activities but are unsure, ask for permission.  If someone opens the door for you, thank them. When strolling on the sidewalk, walking on the side closer to oncoming traffic can be seen as an act of protection. If walking, try to match the pace of your date.  When picking seats at a table perpendicular to a wall, it is traditional that whoever faces the wall signals their lack of interest in scanning the crowd (e.g., for alternative date options). Don't order for your date unless they indicate that preference. Try not to check your phone while on the date. It can send the message that you are bored. Many people advise against discussing politics, religion, marriage, exes, children, or money on the first few dates. However, if one of these topics is important to you, it’s worth sharing early on (e.g., dates 2-5) rather than down the road. If there are deal-breakers on the table, better to find out sooner rather than later. Table manners will help you avoid disgusting your date (e.g., don't chew with your mouth open or talk with a mouth full of food, try not to eat too fast). Don't get drunk on a date. You may think you're charming, but you are likely to look sloppy and say (or do) something you regret. Show an active interest in getting to know your date (e.g., ask questions and refrain from monopolizing the conversation). However, don't pepper your date with questions and refuse to open up. Dating should be a two-way road. Don't interrupt your date. Additionally, avoid constantly interjecting with "uh-huh" or "yeah" as they speak. It's distracting and can send the message you are trying to speed them up. Life is long, and the world is small. Due diligence (both in hiring and dating) is common practice now. Treat others as you would like to be treated (and remembered or spoken of down the line).It is typical (& courteous) to walk or drive your date home. It shows that you care about your date's safety & wellbeing. Alternatively, you can wait until their transportation arrives. For next-level generosity, hail the rideshare from your phone and cover your date's journey. This ensures you know your date arrived home safely. If you had a lovely time on the date, express your thanks graciously (e.g., I had such a great time, would love to see you again"). Had a really great time? Express thanks both in person and with a follow-up text the next day. Grooming & DressingDon't wear clothing that may distract you. If you feel uncomfortable (e.g., too warm/cold/itchy/squeezed), you may appear nervous. Try to dress comfortably so your best self can shine through. Showing a lot of skin can distract your date, making it difficult to focus on a meaningful conversation. Also, it reduces the mystery & intrigue of what might come later. If you hope to touch your date, ensure your nails are clean and filed smooth. Bad breath is a major turn-off. Smell your floss. If it stinks, so does your breath. Body odor is avoidable & easily deterred with light deodorant or antiperspirant. Go easy on the scented type as it can smell like car freshener. Relatedly, while a bit of scent can be nice, overpowering smells may turn off your date. Go light on the cologne/perfume. 1-2 spritzes are generally sufficient. If you think there will be walking, wear shoes you can walk in. Physical Romance: When exploring physical chemistry, consent (ideally enthusiastic) is required. If you sense hesitation from your date, pause. If you doubt your ability to read body language, go slowly. When in doubt, ask your date (e.g., would you like (for me) to XYZ?) If you aren't sure whether or not you are romantically interested in someone, consider getting to know them as a friend first. A true romance typically blooms naturally. It is your duty to disclose anything that could affect your partner's health.If you don't feel comfortable discussing topics related to safe sex (e.g., STDs, testing), reconsider if you are ready to get physical. It is entirely acceptable to require a test before engaging physically with your date.Don't lie (e.g., signal interest in something serious if you aren't).PDA can make others around you feel uncomfortable.  With that said, if a special moment arrives, embrace it. (See this video for inspiration) Ending Things NicelyIf you end a dating relationship with kindness and grace, you open up new opportunities for yourself (e.g., starting a friendship, being introduced to one of their friends). Ending a date early is generally considered rude & will likely hurt your date’s feelings. However, if you are genuinely uncomfortable or have been hurt in some way, it is acceptable to depart early (e.g., after dinner & before dessert). If someone asks you for another date and you don't want to accept, be gracious and thank them. Then turn them down nicely. Do not lead people on. It's cowardly & selfish. When ending things, don’t lie. Lies are unethical and can brand you as a “liar” if caught. If you end something and are sincere about staying friends, let some time pass and follow up with a friendly invitation. If the timing is off, be upfront (e.g., "Thank you for asking me out. I would like to but [insert timing-related issue here]. Would it be okay if I reach back out when things change?")Sample rejection verbiage: "I see this more as a friendship than something romantic"; "I've recently started seeing someone, but thank you."; "I don't think we have enough chemistry."; "I am sorry, but I have a rule to never ___."; "Something is missing."; "The timing isn't right." Accepting Rejection With Grace If someone turns you down, accept it graciously. If, however, you think your rejector has made a grave mistake, it's acceptable to ask for another chance. It is acceptable to ask for feedback if you can abstain from becoming pushy or defensive. Remember that the right guy/gal won't let you get away, there are many fish in the sea, and dates are like streetcars. If you miss one, another one’s on the way. Learning to accept rejection is a part of life. Try not to obsess or take it too personally. It's their loss. Let your friends be there for you. Dating App ProfilesPictures should be equal parts "accounting" & "marketing." Market your strengths (e.g., high-resolution photos in good lighting) and account for who you are (e.g., recent photos that don't hide your face or body). Don't lie about your age or height. (Rounding up half an inch is permissible.)Avoid group photos if at all possible. They require an additional mental load for your prospective date (who likely has swiping fatigue). You may think you look dissimilar from your friends. On a 3x3 inch image, it's often hard to tell.Answer questions in a way that helps someone get a sense of your personality. Sharing that you relish widely popular food/activities/music is unlikely to differentiate you from others. Don't be afraid to ask a friend or family member for help. Sometimes we aren't the best judges of our strengths and quirks. Introducing others: If you want to set two people up, it's best to ask both their permission beforehand, separately. If one person tends to be pickier than the other, ask that person first. Show a picture and make a quick pitch. If they aren't interested, let it go. One easy way to introduce people to one another is to create a scenario where they can meet naturally, in person, in a group setting (e.g., invite them both to an event or party) Introducing people is a great way to put positive karma into the world.  Dating & Money: In theory, the person who initiates the date signals their intent to pay. This goes for suggesting an addition to a date underway as well. It’s polite to at least offer to split the check. Most likely, your offer will be refused (at least on a first date). If you strongly prefer to pay, kindly explain that.If someone pays for you, thank them. Some more traditional types will prefer to pay/be paid for the first few dates. This is something worth discussing if it makes you uncomfortable one way or the other (e.g., "how do you think/feel about paying for dates?")The early stages of dating often transform as a couple builds more trust and talks through preferences around spending money. Do not assume that what happens on the first few dates will be set in stone. Paying for a date should not correlate with any romantic outcomes.If eating at a restaurant and the menu is expensive, try to pick something in the mid-price range or look to your date for guidance (e.g., mimic their general approach). Splitting the check early on (e.g., the first three dates) can be read as a lack of romantic interest — signal at your own risk. 📓Dates by Budget Reference Guide $: walk/hike, coffee/tea, phone call/video chat, local park, museum, volunteering$$: brunch/lunch, movie, drinks, picnic, host for dinner $$$: out to dinner, cultural event (e.g., show, concert)$$$$: trip/vacation📓 Feelings Words Reference Guide: Do you struggle to talk about feelings? Here are some words to help guide/inspire you. Happy: relaxed, calm, playful, silly, delighted, spontaneous, amused, optimistic, joyful, excited, satisfied, content, confident, charmed Anger: annoyed, aggravated, bugged, cranky, disgusted, enraged, fuming, agitated, frustrated, mad, resentful, furious, lividFear: uneasy, tense, nervous, insecure, worried, afraid, frightened, fearful, anxious, shocked, stuck, lost, trapped, helpless, paralyzed, insecure, uncomfortable, unsure Sadness: disappointed, low, down, blue, gloomy, unhappy, hurt, miserable, terrible, crushedFatigued: thirsty, hungry, tired, worn out, shaky, sick, ill, exhausted, stressed, fragile, vulnerable, insecure, discouraged, overwhelmed  Seeking: curious, motivated, energetic, intrigued, engaged, productive, creative, eager, confident, focused, determined, inspired, ambitious, obsessed Caring: helpful, secure, considerate, friendly, loving, connected, understanding, nurturing, attached, tender Romantic: affectionate, tender, frisky, physical, turned on, passionate, flirtatious🎓 Further Study Emily Post's Etiquette, 18th EditionDating Then & Now [Business Insider]F** yes or no by Mark MansonGhosting a Twitter thread by @SahilHow To Not to Die Alone 📖 by Logan UrgyDifficult Conversations 📖 by Douglas Stone, Bruce Patton & Sheila Heen Nonviolent Communication 📖 by Marshall B. Rosenberg The Little Mermaid | Kiss the Girl 🎬 by DisneyLife School’s mission is to improve your quality of living, one new skill at a time. We send a weekly newsletter with three free lessons. This is a public episode. Get access to private episodes at www.trylifeschool.com/subscribe

Forgetfulness leads to a troubled heart (Judges 3:7-11) The Evil of Forgetfulness (3:7) We are not yet three complete chapters into the book of Judges until we experience God's covenant community falling into rebellion and iniquity. Tangentially, one reason you can trust that the Holy Scriptures are inspired by God and not man is that Bible never ignores or excuses Israel's sin.  Man would never let you know about his most profound failures. Israel did evil. The Judeo-Christian worldview gives us a framework for calling evil, evil. Evil is anything against the nature, will, or way of a Sovereign God [in the Lord's sight]. However, when your worldview does not begin with an absolute sovereign Creator, it will lead to a place where you can't call evil by name. Some have tried to explain evil apart from an absolute Good God: Evil skeptics propose describing morally despicable actions, characters, and events using more pedestrian moral concepts such as badness and wrongdoing. The most celebrated evil-skeptic, nineteenth-century German philosopher Friedrich Nietzsche, argued that the idea of evil should be abandoned because it is dangerous. It should come as no surprise that Nietzsche, describing the Enlightenment, retorted, “God is dead. God remains dead. And we have killed him. “ Without Yahweh, you have no framework to label evil. Result: you will live a life that tries to diminish evil (or magnify others) with the hopes that your personal sin will be ignored. In Christ, evil becomes dangerous, but without Jesus, evil sees God as hazardous. May we see the world as God sees. So what is this great evil? The people forgot and worshipped. Forgetfulness is a radically benign way to describe evil and sin, don't you think? Yet, the Bible is full of reminders never to forget God's faithfulness. Moses, speaking to the Exodus generation who witnessed the ten plagues, walked through the Red Sea, read the 10 Commands said: Deut 4:9   “Only be on your guard and diligently watch yourselves, so that you don't forget the things your eyes have seen and so that they don't slip from your mind as long as you live. Teach them to your children and your grandchildren.” King David, the psalmist, penned, “My soul, bless the Lord, and do not forget all his benefits.” What if forgetting the promises of Christ is the greatest threat to your abundant life and spiritual vitality? Never forget! The Consequence of Forgetfulness (3:8) As a result of covenant forgetfulness and evil, the people of God experienced the consequence of their sin. Amid their bold apostasy, the anger of Yahweh burned. Sin always has effects. Romans says that the wages of sin is death! Not all consequences are equal: There is a consequence of God's wrath for those who remain outside His covenant. All die because of sin, but some will experience judgment unmitigated by grace outside his covenant. This judgment is retribution—punishment without grace- for those who reject His lovingkindness. The final permanent expression of Yahweh's retributive justice is Hell. But, the gift of God is eternal life. The consequences of sinful forgetfulness received by Israel were within a covenant relationship. This judgment is discipline—corrective rather than retributive—and always tempered by grace. God will let His children receive the consequences of their sin so that they may run back to His presence. God's discipline in your life is always corrective. The punishment for sin can be immediate or delayed, but it is sure. For those who sold out to the gods of Baal and Asherah, the Lord sold them to King Cushan-rishathaim. His name means dark and doubly wicked or evil times two. For eight years, God's community was slaves to their sin. The punishment for sin can be immediate or delayed, but it is sure. The Cry of Remembrance [Anti-forgetfulness] (3:9). After eight years, someone remembered Yahweh. And they began to cry out! Don't get this confused with a shout of repentance. Fundamentally, this is a roar of anguish in a desperate situation and pain. Even to this superficial plea, the Lord is moved to pity and immediately responds. If you have ever felt like God won't hear your prayer because of your sin or situation, Judges teaches us to cry out! He will listen to and be moved to compassion. Before you even were aware of your sin, God made way for you to know him through Jesus  Christ (Romans 5:8). A wrong call to Christ is better than no call to Him. Even if you are living in the consequences of your sin, God can redeem you. You don't have to stay as a slave to your sin. To see the heart of the Father is to be forever quick to repentance. The Salvation of Remembrance (3:9-10) So is a word of redemption. Because of His mercy, the Lord raised a deliverer, a man named Othniel (God is my strength/protection), from the tribe of Judah (the tribe entrusted to go first). Othniel is an exemplary man of God. When all others intermarried with the Canaanites, Othniel married the daughter of Caleb, the mighty faithful spy. Othniel is the first judge that the Lord raises to rescue His people. The judges (shophetim) were local charismatic leaders and military heroes more than supreme court legislators. However, although Othniel was the first and model judge, the Scriptures call him a deliver and not a judge. Through one man, the covenant community would experience salvation and deliverance until Othniel dies. Many years later, through one God-Man, an entire faith community would be saved. Salvation comes through remembering the sacrifice:  42 Then he said, “Jesus, remember me when you come into your kingdom.” Gathered worship is a way to remember. When we gather, we recite memories of the Lord's tender mercies in our lives. It is not we who save ourselves; salvation comes from above, from God, who is our strength and protection. The Peace of Remembrance (3:11) When the cry of help reaches the ears of the Father, he raises Othniel and brings peace to the land as long as Othniel lives. This peace not only rests upon the people but the entire land. There is no peace like the peace of Jesus! The peace of Yahweh is a gift. Why did Israel receive peace? They cried – an unusual way to earn peace. Peace was the gracious gift of Yahweh, who raised Othniel, put his spirit upon him, and destroyed the king Cushan-rishathaim. You don't earn Christ's peace; you receive it. The peace of Yahweh is the enjoyment of covenant faithfulness. Judges is a stark reminder that you can't earn peace, but you can surely forfeit it. True peace is only enjoyed in covenant relationship to Yahweh through faith in His only begotten Son, Jesus Christ. Enjoy! The peace of Yahweh is absolute and comprehensive. We often speak about the peace of the Lord as if it is some inner peace without tangential qualities like it's some beauty pageant world-peace wish. Peace is not the absence of trouble but the presence of shalom—total well-being. It's the complete peace of knowing that because of Jesus,  whatever my lot, it is well, it is well with my soul. The peace of Christ in your life is real, comprehensive, and eternal. However, the peace through Othniel was only temporary; it lasted forty years. This is the problem with earthly peace; it only lasts as long as the leader is alive. In Judges, the community experiences salvation only as long as the judge is alive. After the judges would come the kings of Israel. After the kings would come the Messiah, Jesus Christ. God does not desire temporary salvation for your life. That is why He sent his only Son as the eternal deliver. So What? Forgetfulness leads to troubled hearts  What if forgetting is one of our greatest sins? Gathering together is one of the Father's antidotes for our spiritual forgetfulness “And remember, I am with you always, to the end of the age.” Will you ask the Father to flood your soul with remembrance of His atoning sacrifice? Will you ask the Father once again never to let you forget or get over your salvation? If you hope that the Lord will forget your iniquities one day, this day will never happen. You can't outlive God's memory. But there can be a day where God will choose not to remember your sin. For I will forgive their iniquity and never again remember their sin (Jeremiah 31:34) In Christ, you find forgiveness for your sins, evil, and forgetfulness. Will you cry out to Him today and receive abundant life by faith in the resurrection? In Christ, you never have to experience God's judgment outside of a covenant relationship. In Christ, you have a Father who chooses not to remember your sins again! If spiritual forgetfulness is the root of a troubled heart, never forget!

The Keepers are back with a very special episode of the podcast!  And though this week is light on news, the Keepers manage to fill the episode with all kinds of fun tangents and anecdotes.  Well, I guess that's kind of like every other episode…isn't it?  Oh, and that's not even what makes this episode […]

University of Colorado-Boulder professors Jeff York and Brad Werner distill entrepreneurship research into actionable insights. CREATIVE DISTILLATION Jeff York | Associate Professor | Research Director
jeffrey.york@colorado.edu Brad Werner | Instructor | Teaching Director
walter.werner@colorado.edu Deming Center for Entrepreneurship | CU Leeds School of Business
303.492.9018 | deming@colorado.edu — EPISODE 21: Ada Lovelace gin and the Efficacy of University Entrepreneurship Programs 
On Episode 21 -- kicking off Season 3 of Creative Distillation! -- Brad and Jeff speak with Chuck Eesley, Associate Professor at the Stanford University School of Engineering. While enjoying some negronis mixed with Ada Lovelace gin, Chuck shares a brief but fascinating history of Ada, widely considered to be the first computer programmer (from the mid-19th century!). Tangentially, Brad brings up bitters and Jeff's over/underuse of them in this particular(ly strong) cocktail. This segues to an insightful (and fun) conversation about Chuck and Yong Suk Lee's research on the efficacy of university entrepreneurship programs. The results may surprise you. Learn more about Chuck: https://www.linkedin.com/in/eesley/ Read the paper: https://onlinelibrary.wiley.com/doi/full/10.1002/smj.3246 Comments/criticism/suggestions/feedback? We'd love to hear it. Drop us a note at CDpodcast@colorado.edu. Thanks for listening. - An Analog Digital Arts Production for the Deming Center for Entrepreneurship
Produced, recorded and edited by Joel Davis "AcidJazz" by Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0
creativecommons.org/licenses/by/3.0/

Listen to us draw parallels between the crime of the century and the crime of the century of our generation!

After years of studying abroad, prodigal daughter Kaitlin returns to her familial abode, The House on Arbor Hill, only to find it mysteriously deserted. She feels a pit form in her stomach and sink to its deepest depths. What tragedy befell the household she so cruelly abandoned? Who hid the bodies? And is she truly alone or is she haunted by the specter of her abusive grand uncle Oscar? “Aha,” Jens exclaimed. “Another clue!” “It's about music again, isn't it?”, Randy replied with weary resignation. “Tangentially yes, my dear Randy”, Jens extemporated excitedly. “You see, when Bandcamp abbreviates the Gone Home Original Soundtrack, it spells G.H.O.S.T. - that can't be a coincidence.” OR IS IT!?! Listen to find out IF YOU DARE!! Please help support the show and the entire W2M Network by taking advantage of our 30 Day Free Trial offer of Amazon Music Unlimited by signing up via our link: http://getamazonmusic.com/w2mnetwork. We have a special offer available to sign up for Grammarly as well at: http://getgrammarly.com/w2mnetwork

Tom Jones [00:21] "Hi Heel Sneakers" Live at Caesar's Palace Parrot 2XPAS 71049 / 50 1971 A pretty decent rendition of the Tommy Tucker classic. And in case you were unfamiliar, Tom was quite popular with the ladies. Pavement [03:38] "Painted Soldier" Live Europaturnén MCMXCVII Matador OLE CCCXXIV-1 2008 This record was included with the 2008 reissue of Pavement's 1998 album Brighten the Corners and features a bootleg package design. Otis Redding [06:18] "Shake" Live in Europe Volt Records S-416 1967 Otis backed by Booker T & the MGs playing the heck of Sam Cooke's tune. Tom Jones [09:14] "Hard to Handle" Live in Vegas Parrot XPAS 71031 1969 Tom takes a pass at Otis with this live track recorded live at The Flamingo. Tangentially related, turns out Tom was able to hold is own with Janis Joplin (https://youtu.be/mZmiefQ5y4U). Thee Oh Sees [12:58] "I Come from the Mountain" Live in San Francisco Castle Face CF-075 2016 You'd think it would be hard to capture the energy of an Oh Sees show. You'd be wrong. Kenny Rogers & the First Edition [16:10] "Just Dropped In [to See What Condition My Condition Was In]" Live Vegas '72 Maplewood Records MWR00002 2015 Look out for those bowling pins. Marvin Gaye [19:33] "What's Going On" Live! Tamla T6-333S1 1974 Recorded live at the Oakland Coliseum! Spinners [24:23] "Fascinating Rhythm" Spinners Live! Atlantic SD 2-910 1975 Strong move, opening with a Gershwin number. Tom Jones [27:56] "Shake" Live! At Talk of the Town Parrot PAS 71014 1967 Shakin cover of Sam Cooke. The Living Christmas Tree Youth Choir [30:26] "Jazz Gloria" The Living Christmas Tree Youth Choir Chapel Records CPS 7374 1973 Woof. Well for starters, I'd say that's more rockin' than jazzin'. Hey you kids! Get outta my Yggdrasil! Eddie Arnold [33:43] "Cattle Call" The Living Legend of Eddy Arnold K-Tel WC 307 1974 This 70s compilation features an "autographed" 8x10! David Bowie [36:42] "Red Sails" Lodger RCA Victor AQL 1-3254 1979 A Neu!-esque outing from Bowie's third and final installment of the Berlin trilogy. Herb Alpert & the Tijuana Brass [41:30] "Mexican Road Race" S.R.O. A&M Records SP 4119 1966 Wait, wha'ts this doing here? Well, the album cover this record is in was their 1962 release The Lonely Bull. I guess someone wasn't to mindful about which Tijuana Brass record goes in what sleeve. Rod McKuen [46:42] "Morning - San Francisco" Lonesome Cities Warner Bros. - Seven Arts Records W 1758 1968 Whodda thought? Winner of the Grammy's best spoken word recording in 1968. Faces [46:42] "Maybe I'm Amazed" Long Player Warner Bros. Records WS 1892 1971 Recorded live at the Fillmore East in November of 1970, with Rod and Ronnie on vox. Luna [52:14] "California (All the Way)" Long Players 92-99: Bewitched Captured Tracks CTBOX-005 2016 No really, would you please stop quoting Rod McKuen in your postcards?finder Music behind the DJ: "Summer Samba" by Duke Ellington & his Orchestra

Jesse Trucks is the Minister of Magic at Splunk, where he consults on security and compliance program designs and develops Splunk architectures for security use cases, among other things. He brings more than 20 years of experience in tech to this role, having previously worked as director of security and compliance at Peak Hosting, a staff member at freenode, a cybersecurity engineer at Oak Ridge National Laboratory, and a systems engineer at D.E. Shaw Research, among several other positions. Of course, Jesse is also the host of Meanwhile in Security, the podcast about better cloud security you're about to listen to.Show Notes:Links:Information Security Compliance: Which regulations relate to me: https://www.tcdi.com/information-security-compliance-which-regulations/ TranscriptJesse: Welcome to Meanwhile in Security where I, your host Jesse Trucks, guides you to better security in the cloud.Announcer: If your mean time to WTF for a security alert is more than a minute, it's time to look at Lacework. Lacework will help you get your security act together for everything from compliance service configurations to container app relationships, all without the need for PhDs in AWS to write the rules. If you're building a secure business on AWS with compliance requirements, you don't really have time to choose between antivirus or firewall companies to help you secure your stack. That's why Lacework is built from the ground up for the cloud: Low effort, high visibility, and detection. To learn more, visit lacework.com.Jesse: Compliance requirements are everywhere. I've been on both sides of the table for dozens of audits, and I've even worked on commercial building fire code compliance for data centers and even a school. Whatever your industry, there are compliance requirements lurking somewhere in your buildings, your data center, and your clouds. You should know what legal compliance mandates you must meet as well as industry standards or certifications you should meet. You don't have to learn all the intricate details of any of these compliance laws or frameworks, however, you should at least know what the requirements you have and what frameworks you should use.You need to understand more than what your organization does at a high level. You also should know what general activities your organization performs, such as selling things, providing services to a public, or quasi-public entity, or government agencies, or schools, or managing investments or banking. Then go find out your compliance needs. An article called Information Security Compliance: Which regulations relate to me? By TCDI—which appears to be a consulting firm that I neither endorse nor know anything about at all—is a short primer on some common compliance programs that really should prove useful to you.Meanwhile, in the news, SANS cloud security curriculum gaining altitude. Become a SANS cloud ace. SANS and GIAC have the best security training and certifications, and now they've expanded their cloud courses, including some more foundational options non-security people should find valuable. The training is detailed, challenging, and rewarding, and will teach you far more than most other programs including hands-on exercises that are key to learning tech.Introduction to the NIST cybersecurity framework. I like the cybersecurity guidelines and frameworks NIST creates because they are useful and understandable tools for non-security and security people I like. I like this introductory primer to better understand structured security frameworks and to start learning how auditors think. Essentials to consider when choosing a cloud security posture management solution; whether your primary job is security or not, I always advocate for a centralized, simplified automation and standardization of security controls wherever possible. For multi-cloud environments, you can outsource to a cloud security posture management—or CSPM—provider, and this quick read has tips I like on some basics to consider for how to choose your solution.SOC 2 attestation tips for SaaS companies. Everyone should understand the basics of service organization control type two, more commonly known as SOC 2, as it is fundamental to doing business in the cloud. SOC 2 is especially important for SaaS providers because it shows there are certain safeguards for data confidentiality, integrity, and availability, among other things.Enterprises need to change passwords following ClickStudios' Passwordstate attack. Tangentially related to cloud, password managers are great tools as long as they are secure, but if you use this one you need to know two things. First, you have to change all your passwords, and second, you need to search for indicators of compromise—or IOCs—for possible nasty things in your environment.Five objectives for establishing an API-first security strategy. With cloud-native services APIs become an easy target, so you need to know how to design their use securely. I would use these tips in designing a SaaS offering, so you should too. Hackers are exploiting a Pulse Secure Zero-Day to breach orgs around the world. You need to trust your zero trust solution, and if you use Pulse Secure, you need to know what to do about this right now. If you don't use Pulse Secure, you should still understand what happened so you can be prepared for when this happens to you.Announcer: This episode is sponsored by ExtraHop. ExtraHop provides threat detection and response for the Enterprise (not the starship). On-prem security doesn't translate well to cloud or multi-cloud environments, and that's not even counting IoT. ExtraHop automatically discovers everything inside the perimeter, including your cloud workloads and IoT devices, detects these threats up to 35 percent faster, and helps you act immediately. Ask for a free trial of detection and response for AWS today at extrahop.com/trial. That's extrahop.com/trial.Jesse: Man charged with planning to blow up Amazon Web Services data center in Virginia. You should always have your critical services and all of your data in multiple availability zones, and as much as possible spread across multiple regions. Someday, one of these nutters will succeed in disrupting AWS just enough to give you a bad day. Also, it's easy to forget that most people don't know how ‘the cloud' and ‘the internet' actually work. Heck, we barely know how these things work and we're supposed to know this stuff.SalusCare, a health services provider, sues AWS over security response. Sure, anyone can sue anyone for anything, but you need to be careful with your data and even more careful with your customers' data. Does your service agreement and licensing protect and indemnify you from things like this? Even a nuisance lawsuit is costly, so be informed.Risk, the misunderstood discipline. Security and finance people talk about risk constantly and some of us evaluate risk in our daily lives. Yep, I do every day at work and home. You need to understand some fundamentals of risk to know how to make decisions. What are the different roles within cybersecurity? Just like IT is balkanized and specialized, security is just as splintered and confusing. It helps to understand some basic differences in security roles, even if you don't want those jobs for yourself.Review last access information to identify unused ECT, IAM, and Lambda permissions and tighten access to your IAM roles. While the title is a mouthful, it is critical that you routinely and frequently audit your AWS environment to tighten permissions down to only what an account or service must access to do its job. Open permissions you think something needs, then use these methods to see what it doesn't use, and close those down to the minimum required to function.And now for the tip of the week. Always assign permissions to AWS IAM user groups. Never assign permissions to individual users. If a user needs a combination of permissions none of your user groups have in IAM, then create a new group with that combination of permissions, or use multiple existing groups to assign the user the exact set of permissions needed. This is critical for two reasons.First, using groups scales for easier management for when you have more users needing the same permissions; you can quickly end up with lots of users floating about with one-off custom permissions that's more complicated and time-consuming to track and audit. Second, when a project dies or morphs, you can delete or alter the related group permissions to change all the related users at once. In addition, this allows you to work more closely with project teams to roll out security with the new projects. And that's a wrap for the week, folks securely yours, Jesse Trucks.Jesse: Thanks for listening. Please subscribe and rate us on Apple and Google Podcast, Spotify, or wherever you listen to podcasts.Announcer: This has been a HumblePod production. Stay humble.

Good morning, RVA! It’s 65 °F, and today you should expect another warm and awesome day with temperatures returning to the mid 80s for at least the next two days. Get out there and enjoy it!Water coolerAs of this morning, the Virginia Department of Health reports 1,105 new positive cases of the coronavirus in the Commonwealthand 18 new deaths as a result of the virus. VDH reports 128 new cases in and around Richmond (Chesterfield: 52, Henrico: 49, and Richmond: 27). Since this pandemic began, 1,273 people have died in the Richmond region. The seven-day average of new reported cases across the state sits at 1,098.Yesterday, the CDC released new guidance on wearing masks outside and put together this helpful page about “choosing safer activities.” I really like the framing of information on this page, putting common activities on a spectrum of risk for both vaccinated and unvaccinated folks (rather than a prescriptive DO this or DON’T DO that). The big change is that the CDC now says both vaccinated and unvaccinated people can, unmasked, “walk, run, or bike outdoors with members of your household” and “attend a small, outdoor gathering with fully vaccinated family and friends.” This is great news for tweens patiently (or not so patiently) waiting for the FDA to authorize the Pfizer vaccine for 12–15 year olds. Don’t throw away your masks, though, because you’ll still need them for crowded outdoor events or almost all indoor situations. This is life for a long while, I think!And, just as a reminder, all Virginians aged 16 and older (sorry tweens) are eligible for vaccination. Richmonders and Henricoans can now go to vax.rchd.com and schedule an appointment for themselves directly—no more pre-registration!—or call 804.205.3501 and have an appointment scheduled over the phone. We’re no longer in a place where demand for the vaccine far outstrips supply, so finding an appointment to get jabbed has never been easier.Richmond Police are reporting a shooting on the 4000 block of Midlothian Turnpike involving five people. Here’s the statement from the police: “At 6:31 p.m., Richmond Police responded to the 4000 block of Midlothian Turnpike for a shooting. Officers arrived on scene and located two adult females, two teenagers, and one child suffering from gunshot wounds. The victims were transported to a local hospital, two with non-life threatening injuries, two victims with life-threatening injuries, and one adult female succumbed to her injuries while at the hospital.” And here’s a brief statement from Mayor Stoney: “Earlier this evening, five innocent bystanders in our city were shot, one fatally, in a single, senseless act of gun violence. This is a tragedy that no community should have to experience. My heart aches for our families. The investigation is ongoing, and we will continue to monitor the situation. If you know anything, please say something. Call Crime Stoppers at (804) 780–1000.”Chris Suarez at the Richmond Times-Dispatch has some really interesting casino updates on the thoughts and feelings of local civic associations. For example, the Richmond Highway Neighborhood Civic Association supports the proposed 8th District location, meanwhile “nearly a dozen neighborhood groups in the Fan District and North Side are opposing” the proposed 2nd District location. On my walks and rides through the Northside, I’ve definitely seen “No Casino @ Bowtie” signs (as seen above) pop up in the last week or so—even as far away as Ginter Park. It’ll be real interesting to see how much the public support/opposition plays into the final decision made by the City’s evaluation panel.Tangentially related and directly a bummer, Gregory J. Gilligan, also at the RTD, says Movieland has scrapped its plans to build a drive-in movie theatre in its parking lot this summer.Yesterday, I mentioned RPS’s #ReopeningWithLove2.0 community conversations—Northside, your conversation is up next on May 4th. In the meantime, if you’re interested in learning more about the District’s reopening plans, you should read Superintendent Kamras’s email from yesterday. He’s got a partial list of health and safety measure that families, students, and teachers should expect when school reopens this fall along with three guiding principles for reopening: 1) Extend grace and love to all students, staff, and families, 2) Protect everyone’s health and safety, including their mental health, and 3) Communicate, communicate, communicate. If you’ve been paying attention, these are basically his three guiding principles for all things, but they fit really well here, too. I especially appreciate the first! Folks reentering the world will do so at their own pace and face their own challenges, and we should all be supportive of that!City Council’s second budget amendment sessions is up on The Boring Show, and actual City Council, not the podcast version, will meet today for their third amendment work session. Based on Roberto Roldan’s tweet from earlier this week, it sounds like Council still has a lot of work to do. Speaking of, here’s Roldan’s write up of Council’s decision not to move forward with an unvetted salary increase for police and fire employees—an increase that would have been in addition to and outside of the approved Gallagher compensation study. I’m still kind of surprised Council even considered it.Now that the rad Ms. Bee’s parklet has approval from the City, you can help fund part of its construction by chipping in a couple of bucks on this GoFundMe. Even the pre-fabbed parklets popping up around town are expensive, so I imagine an entirely custom, bee-themed parklet will cost a chunk of change. Honestly, I think getting this parklet funded and built is important: Richmond needs to see, with their own eyes, what’s possible with the existing parklet program. Renderings can only do but so much convincing!This morning’s longreadEnvisioning a Federal Program to Increase Transit ServiceOperational funding for public transit is yet another example of federal COVID relief programs that we should just keep doing forever and ever.But the need to invigorate American transit service predated the pandemic. And after the pandemic recedes, a federal program to support transit service could yield immense dividends. In most American cities, the fundamental shortcoming of transit is its sheer scarcity. Buses and trains simply don’t come often enough or connect enough places to be a reliable transportation option. More abundant service promises to unlock economic opportunity for people with low incomes, improve mobility for Black and brown residents who rely on transit the most, and reduce carbon emissions. The current federal transportation policy regime, however, has done little to change the scarcity of transit service.If you’d like your longread to show up here, go chip in a couple bucks on the ol’ Patreon.Picture of the Day

Writer RK Taylor and game developer Carlos Gutierrez explore all things crunch. Topics include the different types of crunch, burnout, the ecological factors that give rise to crunch, appropriate compensation, moral ramifications, and collective action. Tangentially, they also explore sentimentality in video games, untrustworthy bananas, and eating too many ice cream sandwiches. Intro-00:00:00 D-Pad Delights-00:00:49 Deeper Into the D-Pad-00:12:10 Change of Heart-01:11:45 Outro-01:16:35 Special thanks to 8-bit Jazz & Kevin MacLeod for supplying music for the show and Julia Eldred for creating the artwork.

My long time friend Logan came over to talk about drinking experiences and while we decided to have a couple of drinks during the podcast, of course things went a little off course into various tangents.

Ok so. Like. Give us a break on this one ok? We're really sorry, and promise that there's a possibility that it won't happen again. We spent most (not being hyperbolic there) of this episode talking about a certain British Baking Show. Is it related to the book Pole Star? Tangentially, if at all. But oh well. Check this pic of Paullywood if you DARE ooohhh spooookyyyyy. Pole Star by Josephine Myles @td3somepodcast See omnystudio.com/listener for privacy information.

It’s the 199th episode and to celebrate Micheal and Andrew do what they always do – talk about comics. Tangentially still hanging around the 90’s, they read the 4 part Marvel Vs DC crossover and argue a lot over the battles within. So, clear away 100 minutes and get into [...]